	
	
Special Session Antimicrobial Stewardship in Different Scenarios	Chairs Murat Akova (Ankara, Türkiye) Andre Fuchs (Augsburg, Germany) Maddalena Giannella (Bologna, Italy) Angela Huttner (Geneva, Switzerland) Benedikt Huttner (Geneva, Switzerland) Jose Ramon Pano-Pardo (Zaragoza, Spain) Galadriel Pellejero-Sagastizábal (Zaragoza, Spain) Holger Rohde (Hamburg, Germany) Oana Sandulescu (Bucharest, Romania) Jeroen Schouten (Nijmegen, Netherlands) Valentijn Schweitzer (Utrecht, Netherlands) Thomas Tängdén (Uppsala, Sweden) Suzanne Van Asten (Nijmegen, Netherlands) Dafna Yahav (Ramat-Gan, Israel) Co-organised with: ESCMID Education Subcommittee
	
Educational Session Surgical site infections: principles and practice in the era of multidrug resistance	Chairs Gabriel Birgand (Nantes, France) Efthymia Giannitsioti (Athens, Greece)
	
Evolving antimicrobial resistance: do we need a change in surgical antimicrobial prophylaxis?	Camilla Rodrigues (Mumbai, India)
	
Role of decolonisation and bowel decontamination in regions of overwhelming multidrug resistance	Prasannakumar Palanikumar (Vellore, India)
	
Screening for MDR GNR coloniSation: is there evidence for prophylaxis	Elisabeth Presterl (Vienna, Austria)
	
Perioperative prophylaxis in special populations in the era of MDR	Divyashree Shanthamurthy (Mumbai, India)
	
Educational Session Demystifying pharmacokinetics and population pharmacokinetics: a toolkit for non-experts	Chairs Shampa Das (Liverpool, United Kingdom) João Paulo Telles (Sao Paulo, Brazil)
	
Pharmacokinetics 101: navigating the basics for optimal dosing	Linda Aulin (Leiden, Netherlands)
	
The ABCs of population pharmacokinetic models	Erwin Dreesen (Leuven, Belgium)
	
Looking into the crystal ball: exploring the fabulous world of PK-PD simulations Vincent Aranzana-Climent (Poitiers, France)	
	
Decoding population pharmacokinetic papers: interpreting, comparing and discussing results Iris K. Minichmayr (Vienna, Austria) Co-organised with: ESCMID PK/PD of Anti-Infectives Study Group (EPASG)	
	
Educational Session Challenges in identification and relevance of slow-growing pathogens	Chairs Kerrie Davies (Leeds, United Kingdom) Yann Dumont (Nancy, France)
	
Sampling and culturing anaerobes	Hugo Cruz (Porto, Portugal)
	
I have an anaerobe: what is it and does it matter?	Kathleen Boiten (Groningen, Netherlands)
	
Actinomyces in clinical samples: when is it worth the trouble?	Eija Inkeri Könönen (Turku, Finland)
	
Nocardiosis: when to test and how to manage results?	David Lebeaux (Paris, France) Co-organised with: ESCMID Study Group for Anaerobic Infections (ESGAI), ESCMID Study Group for Clostridioides difficile (ESGCD)
	
Educational Session A hard nut to crack in HIV	Chairs Yoav Keynan (Winnipeg, Canada) Justyna Kowalska (Warsaw, Poland)
	
Viral reservoir: what a physician should know	Ivailo Alexiev (Sofia, Bulgaria)
	
Non-suppressible viraemia during HIV-1 therapy: a challenge for clinicians	Jose Arribas (Madrid, Spain)
	
Chronic vascular and pulmonary disease and HIV: what can we do about it?	Susanne Dam Poulsen (Copenhagen, Denmark)
	
Opportunistic infections: most common and most deadly Milena Stevanovikj (Sopje, North Macedonia, Republic of) Co-organised with: Euroguidelines in Central and Eastern Europe Network Group	
	
Educational Session Diagnostic parasitology in the XXIst century: is microscopy “+” still useful?	Chairs Miriam José Álvarez-Martínez (Barcelona, Spain) Caroline Rönnberg (Stockholm, Sweden)
	
Artificial Intelligence for the diagnosis of parasitic infections	Bobbi Pritt (Rochester, United States)
	
Histopathology of parasitic infections	Richard Bradbury (Townsville, Australia)
	
Molecular diagnosis vs. microscopy in the diagnosis of parasitic infections	Sitara Sr Ajjampur (Vellore, India)
	
Paleoparasitology: what diagnostic tools?	Ayman El- Badry (Cairo, Egypt) Co-organised with: ESCMID Study Group for Clinical Parasitology (ESGCP)
	
Educational Session Vaccine hesitancy: from issues to solutions through developing communication skills	Chairs Monia Chemais (Soignies, Belgium) Petar Velikov (Sofia, Bulgaria)
	
Vaccine hesitancy and its consequences	Noni Macdonald (Halifax, Canada)
	
Why are patients and parents hesitant about vaccination?	Eve Dube (Quebec City, Canada)
	
Using social media to deal with vaccine hesitancy Muge Cevik (St Andrews, United Kingdom) ESCMID Global 2025 - Programme	
	
Strengthening vaccine confidence in patients and parents Tba Co-organised with: ESCMID Vaccine Study Group (EVASG)	
	
Special Session Principles of systematic reviews (with and without meta-analysis)	Chairs Chiara Iaria (Palermo, Italy) Miranda Langendam (Amsterdam, Netherlands) Blin Nagavci (Gjakove, Kosovo) Mical Paul (Haifa, Israel) Luigia Scudeller (Pavia, Italy) Co-organised with: ESCMID Education Subcommittee
	
Meet-the-Expert How to interpret resistance patterns from antibiograms	
	
Tommaso Giani (Florence, Italy)	
	
Diaz Lorena (Santiago, Chile)	
	
Meet-the-Expert Children are not just small adults: interactive paediatric cases	
	
Julie Toubiana (Paris, France)	
	
Sanjay Patel (Winchester, United Kingdom)	
	
Meet-the-Expert How to practise WHO Guidelines for the prevention of bloodstream infections and other intravascular catheter infections	
	
Kushlani Jayatilleke (Battaramulla, Sri Lanka)	
	
Walter Zingg (Zurich, Switzerland)	
	
Meet-the-Expert Can we stop vertical transmission of syphilis, HIV and hepatitis?	Regional experience
	
Ecaterina Noroc (Chisinau, Moldova, Republic of)	
	
Fakhriddin Nizamov (Almaty, Kazakhstan) Co-organised with: Euroguidelines in Central and Eastern Europe Network Group, United Nations International Children&#39;s Emergency Fund (UNICEF)	
	
Meet-the-Expert Biofilm-related nontuberculous mycobacterial infections: ongoing nightmare	
	
Jaime Esteban (Madrid, Spain)	
	
Philippe Morand (Paris, France) Co-organised with: ESCMID Study Group for Implant-associated Infections (ESGIAI), ESCMID Study Group for Mycobacterial Infections (ESGMYC)	
	
Meet-the-Expert How to understand infectious disease risks in changing climates	
	
Kimberly Fornace (Singapore, Singapore)	
	
Rachel Lowe (Barcelona, Spain)	
	
Special Session Top five mistakes in Infection prevention and control	Chairs Maeve Doyle (Waterford, Ireland) Barbara Juliane Holzknecht (Copenhagen, Denmark) David Ong (Zoetermeer, Netherlands) Arjana Tambic Andrasevic (Zagreb, Croatia) Co-organised with: ESCMID Education Subcommittee
	
Meet-the-Expert Orthopaedic implant infections: new approaches for improved outcomes	
	
Marjan Wouthuyzen-Bakker (Groningen, Netherlands) 	
	
Trisha Peel (Melbourne, Australia) Co-organised with: ESCMID PK/PD of Anti-Infectives Study Group (EPASG), ESCMID Study Group for Implant-associated Infections (ESGIAI), ESCMID Study Group for Infectious Diseases of the Brain (ESGIB)	
	
Meet-the-Expert Timing of antimicrobials in sepsis and septic shock - the sooner the better?	
	
Laura Evans (Seattle, United States)	
	
Evangelos Giamarellos-Bourboulis (Athens, Greece) Co-organised with: ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES), ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS)	
	
Meet-the-Expert PrEP in Europe: Current gaps and solutions	
	
Teymur Noori (Stockholm, Sweden)	
	
Milosz Parczewski (Szczecin, Poland) Co-organised with: European AIDS Clinical Society (EACS)	
	
Meet-the-Expert Short regimens for treating drug-susceptible and drug-resistant tuberculosis: Insights from guidelines ESCMID Global 2025 - Programme	
	
Daria Podlekareva (Copenhagen, Denmark)	
	
Raquel Duarte (Porto, Portugal) Co-organised with: European Respiratory Society (ERS)	
	
Meet-the-Expert How to navigate Risk Communication in Public Health	
	
Christina Rolfheim-Bye (Oslo, Norway)	
	
Marius Gilbert (Brussels, Belgium) Co-organised with: ESCMID Study Group for Public Health Microbiology (ESGPHM)	
	
Meet-the-Expert Do we need antiviral stewardship in immunocompromised hosts?	role of cell- mediated immunity
	
M0048	13:30	13:42	Michelle Yong (Melbourne, Australia) Genovefa Papanicolaou (New York, United States)
	
Special Session Hall 0 Science Slam - How to Communicate Science with Clarity	Chairs Mary Horgan (Dublin, Ireland) Jaroslav Hrabak (Plzen, Czech Republic) Nina Khanna (Basel, Switzerland) Preeti Malani (Ann Arbor, United States) Emily G. Mcdonald (Montreal, Canada) Joshua Nosanchuk (Bronx, United States) Jesús Rodríguez-Baño (Seville, Spain) Co-organised with: ESCMID Education Subcommittee
	
Meet-the-Expert Healthcare-associated CNS infections	
	
Diederik Van De Beek (Amsterdam, Netherlands)	
	
Alexandra Mailles (Paris, France) Co-organised with: ESCMID Study Group for Infectious Diseases of the Brain (ESGIB)	
	
Meet-the-Expert Translation of gut microbiome data to clinical practice: a guide for clinicians	
	
Aycan Gundogdu (Kayseri, Türkiye)	
	
Niranjan Nagarajan (Singapore, Singapore) Co-organised with: ESCMID Study Group for Host and Microbiota Interaction (ESGHAMI)	
	
Meet-the-Expert How to make sense out of guidelines and scientific evidence	
	
Luigia Scudeller (Pavia, Italy)	
	
Blin Nagavci (Gjakove, Kosovo) Co-organised with: ESCMID Guidelines Subcommittee	
	
Meet-the-Expert Multidisciplinary management of bone and joint infections: is there a recipe for success?	
	
Natividad Benito (Barcelona, Spain)	
	
Tiziana Ascione (Naples, Italy) Co-organised with: ESCMID Study Group for Lyme Borreliosis (ESGBOR)	
	
Meet-the-Expert How to manage and prevent travellers&#39; diarrhoea	
	
Tinja Laaveri (Helsinki, Finland)	
	
David Tribble (Bethesda, United States)	
	
Meet-the-Expert How to diagnose and treat infectious complications in critically ill patients receiving ECMO support	
	
Jordi Riera (Barcelona, Spain)	
	
Giacomo Grasselli (Besana In Brianza, Italy) Co-organised with: European Extracorporeal Life Support Organization (EuroELSO)	
	
Special Session Multidisciplinary approach to early sepsis management	Chairs Markus Bald (Lüdenscheid, Germany) Aleksandra Davidovic (Luedenscheid, Germany) Charalambos Dokos (Lüdenscheid, Germany) Co-organised with: ESCMID Education Subcommittee
	
Educational Session AMR surveillance: current challenges and new perspectives	Chair Tomislav Mestrovic (Varazdin, Croatia)
	
The essentials of GRAM project: data sources, methodology and challenges in estimating AMR burden	Authia Gray (Washington, United States)
	
Networks for surveillance of AMR in animal pathogens	Lucie Collineau (Lyon, France)
	
Transition to genomic-based methodology for surveillance and outbreak detection to effectively combact AMR	Camilla Wiuff Coia (Copenhagen, Denmark)
	
Implementing and running hospital-wide genomic surveillance of pathogens Alexander Mellmann ESCMID Global 2025 - Programme (Münster, Germany) Co-organised with: ESCMID Education Subcommittee, ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS), ESCMID Study Group for Veterinary Microbiology (ESGVM)	
	
Educational Session New insights into antifungal agents and resistance	Chairs Anuradha Chowdhary (New Delhi, India) Jon Salmanton-Garcia (Cologne, Germany)
	
Emerging resistance in Candida tropicalis	Sharon Chen (Sydney, Australia)
	
Mechanisms of resistance in Candida glabrata	David Perlin (Nutley, United States)
	
Surveillance of resistance in Aspergillus species	Maiken Cavling Arendrup (Copenhagen, Denmark)
	
Environmental surveillance for antifungal resistance	Eveline Snelders (Wageningen, Netherlands)
	
Educational Session Going Viral! Phage Therapy Clinical rounds	Chairs Gregory German (Maple, Canada) Ameneh Khatami (Sydney, Australia)
	
Clinical cases and lessons from the STAMP protocol	Holly Sinclair (Nsw, Australia)
	
Difficult cases treated with phages	Ghady Haidar (Pittsburgh, United States)
	
Challenging osteoarticular cases treated with phages	Tristan Ferry (Lyon, France)
	
Treating urinary tract infections with phages: dream or reality?	Saima Aslam (San Diego, United States) Co-organised with: ESCMID Study Group for Non-traditional Antibacterial Therapy (ESGNTA)
	
Educational Session Addressing infection challenges in immunocompromised patients: a case- based exploration	Chairs Maddalena Giannella (Bologna, Italy) Asma Nasim (Karachi, Pakistan)
	
Challenges in managing gastrointestinal infections in patients with primary immunodeficiency Effrossyni Gkrania-Klotsas (Cambridge, United Kingdom)	
	
Respiratory infections in patients receiving CAR-T cells or bispecific monoclonal antibodies	Gemma Reynolds (Heidelberg, Australia)
	
Mycobacterial infections in patients with HIV infection	Graeme Ayton Meintjes (Observatory, South Africa)
	
Breakthrough fungal infections in haematopoietic cancer and in stem cell transplantation Dimitrios P. Kontoyiannis (Houston, Tx, United States) Co-organised with: ESCMID Study Group for Respiratory Viruses (ESGREV), International Immunocompromised Host Society (ICHS)	
	
Educational Session Impact of diabetes on infectious diseases: what should we know?	Chairs Mark G. J. De Boer (Leiden, Netherlands) Suzanne Van Asten (Nijmegen, Netherlands)
	
The impact of diabetes and host-pathogen interaction and gut microbiome	Reinout Van Crevel (Nijmegen, Netherlands)
	
Diabetes and invasive fungal infections	Jochem Buil (Nijmegen, Netherlands)
	
Viral infections and diabetes: is there a connection?	Malin Flodström-Tullberg (Stockholm, Sweden)
	
Pathogenesis of diabetic wound infection Tba	
	
Educational Session Primer on infection prevention and control: the crucial support by clinical microbiology	Chairs Nico Tom Mutters (Bonn, Germany) Margreet C. Vos (Rotterdam, Netherlands)
	
Microbial fundamentals: building blocks of infection prevention and control Laurence Armand-Lefevre (Paris, France)	
	
Optimising environmental sampling in infection control: rational use of the microbiology laboratory John E. Coia (Esbjerg, Denmark)	
	
The crucial role of molecular typing in infection control	Stefanie Kampmeier (Würzburg, Germany)
	
How can we link diagnostic and antibiotic stewardship?	Constantinos Tsioutis (Nicosia, Cyprus) Co-organised with: ESCMID Study Group for Nosocomial Infections (ESGNI), EUCIC Steering Committee 
	
	
	
2-hour Symposium The quality of antibiotics used in the communities of LMICs	Chairs Thi Thuy Nga Do (Ha Noi, Vietnam) Christina Obiero (Kilifi, Kenya)
	
The quality of antibiotics and their potential impact on patient outcome and AMR	Paul Newton (Oxford, United Kingdom)
	
Community antibiotic access and use in Sub-Sahara Africa Samuel Afari-Asiedu (Kintampo, Ghana)	
	
Encountered challenges and reflections on conducting multi-country medicine quality studies	Noudy Sengxeu (Vientiane Capital, Lao People&#39;s democratic republic)
	
Confusion in appearance of common used antibiotics in LMICs	Heiman Wertheim (Nijmegen, Netherlands)
	
2-hour Symposium To screen or not to screen prior to transplant?	Chairs Laura Alicia Barcan (Buenos Aires, Argentina) Oscar Len (Barcelona, Spain)
	
HHV-8 Screening	Alessandra Mularoni (Palermo, Italy)
	
TB screening and prevention in endemic regions Rubina Naqvi (Karachi, Pakistan) ESCMID Global 2025 - Programme	
	
Screening for and prevention of chagas in immunocompromised hosts Marcelo	Victor Radisic (Buenos Aires, Argentina)
	
Screening of lung donors for Molicutes	Michael G Ison (Derwood (MD), United States)
	
ePoster Flash Session On the frontiers of vaccine driven prevention	Chair Maria Ganczak (Zielona Gora, Poland)
	
Changes in dose interval can impact T cell responses but not antibody levels in individuals receiving the modified vaccinia Ankara Mpox vaccine J. Parsons* (Liverpool, United Kingdom), K. Subramaniam, L. Turtle, S. Dobson, L. Goodwin, C. Jones, T. Jones, P. Shellman, A. Uriel, S. Jones, A. Otter, S. Laidlaw, M. Carroll	
	
A phase 1 study with an innovative approach for an HIV-1 prophylactic vaccine P. Garbes* (Newark, United States), C. Chang, H. Wraight, R. Norton, S. Ouyang, S. Shen, H. Gao, D. Montefiori, J. Heptinstall, S. Sawant, G. Tomaras, J. Zhu, K. Braz Gomes, M. Giffear, K. Damjanoska, J. Li	
	
A Pragmatic Randomized Trial to Evaluate Bivalent RSV Prefusion F Protein–based Vaccine Effectiveness for Preventing RSV Hospitalizations in Older Adults (DAN-RSV): Rationale &amp; Trial Design M. Lassen* (Copenhagen, Denmark), S. Christensen, N. Johansen, K. Skaarup, D. Modin, B. Claggett, C. Larsen, L. Larsen, L. Wiese, M. Dalager-Pedersen, M. Lindholm, L. Køber, S. Solomon, J. Jensen, C. Martel, C. Schwarz, E. Gonzalez, M. Skovdal, P. Zhang, B. Gessner, N. Aliabadi, E. Begier, T. Biering-Sørensen	
	
Six-month Immunogenicity of mRNA-1345 RSV Vaccine in Adults Aged ≥60 Years M. Desai* (Cambridge, United States), E. Comstock, L. Lan, A. Kapoor, F. She, C. Reuter, J. Goswami, F. Priddy, R. Das	
	
Comparative Immune Responses to Homologous and Heterologous SARS-CoV-2 Vaccination Using DNA and Protein Platforms S. Prieto Martin Gil* (Madrid, Spain), S. Prieto Martín Gil, M. López Siles, J.A. Infantes Lorenzo, E. Lorente, D. Fousteris, B. Cano Castaño, A. Tajuelo, D. López, V. Mas Lloret, E. Gato, A. Pérez, M.J. Mcconnell	
	
Quantitative correlates of protection against SARS- CoV-2 variants using individual-level reconstructed antibody kinetics T. Russell* (London, United Kingdom), E.C. Wall, A.J. Kucharski, J. Hellewell, O. Hague, H. Townsley, J. Gahir, M. Shawe-Taylor, D. Greenwood, R. Harvey, M.Y. Wu, D.L. Bauer, E.J. Carr	
	
Effectiveness of the 2023-24 seasonal influenza vaccine in UK healthcare workers: results from the SIREN prospective cohort study L. Mcgeoch* (London, United Kingdom), S. Foulkes, H. Whitaker, K. Munro, J. Khawam, D. Sparkes, A. Charlett, C. Brown, A. Atti, J. Islam, S. Hopkins, N. Andrews, V. Hall	
	
Immunogenicity and safety of second COVID-19 booster and Influenza vaccination coadministration I. Wagenhäuser* (Würzburg, Germany), J. Reusch, J. Mees, A. Gabel, N. Petri, M. Krone	
	
The degree of immunization against the Measles virus of the infant population in Sibiu county, Romania S. Cristea* (Sibiu, Romania), C. Grigore	
	
ePoster Flash Session Pharmacology from bench to the bedside	Chair Alina Karoline Nussbaumer-Pröll (Wien, Österreich, Austria)
	
Enterococcus faecalis impairs Escherichia coli response to antibiotics in a dual-species intracellular infection model F. Van Bambeke* (Brussels, Belgium), G. Wang	
	
In vitro investigations of ceftazidime-avibactam and fosfomycin against carbapenemase-producing Enterobacterales clinical isolates M. Martens* (Hamburg, Germany), F.M. Docobo-Perez, C. Sauco Carballo, J. Rodriguez-Baño, S. Marchand, L. Keomany, I. Portillo-Calderon, M. Gianella, S. Ambretti, B. Secci, S.G. Wicha	
	
In vivo activity and PK of the novel siderophore- cephalosporin AR-2126 in a lethal lung infection model in mice infected with a carbapenem-resistant Pseudomonas aeruginosa following subcutaneous administration W. Wicha* (Bruck An Der Leitha, Austria), S. Paukner	
	
Synergistic Potency Unveiled: -Lactam and - Lactamase Inhibitor Combination against Mycobacterium abscessus with Dual Action of - Lactamase Inhibition and Multi-Target Receptor Inactivation E. Shin* (Cleveland, United States), K.M. Dousa, C.R. Bethel, M. Nantongo, S.M. Holland, E.J. Rubin, J.B. Bulitta, K. Barry, R.A. Bonomo	
	
Pharmacokinetic/pharmacodynamic evaluation of benzoxaborole MRX-5 in mouse pneumonia model with Mycobacterium abscessus infection W. Wang* (Foster City, United States), S. Liu, B. Rimal, Y. Xu, Q. Dai, G. Lamichhane	
	
Pharmacokinetic/pharmacodynamic modelling of immune response and meropenem activity in immunocompetent and neutropenic mouse lung infection models R. Saporta* (Uppsala, Sweden), N. Tassi, O. Ticha, V. Biordi, A. Ginosyan, I. Loryan, E.I. Nielsen, I. Bekeredjian-Ding, B. Kerscher, L.E. Friberg	
	
Implementation of a model-based nomogram for amoxicillin precision dosing in patients suspected of infective endocarditis: preliminary results of the NOMOBA-AMX multicentre study P. Le Turnier* (Cayenne, French Guiana), S. Jamard, A. Lorleac&#39;h, C. Deschanvres, F. Andry, A. Coste, P. Danneels, T. Guimard, P. Gicquel, H. Harrabi, N. Issa, J.B. Lainé, R. Lamberet, A. Le Bot, M. Maillet, P. Petitgas, V. Rabier, S. Sunder, J.M. Turmel, D. Boutoille, C. Delaunay, M. Grégoire, A.G. Leroy, M. Wargny, R. Bellouard	
	
No time to waste: hospital-wide assessment of IV- vial and line residuals and impact on target attainment. D. Vanneste* (Leuven, Belgium), M. Gijsen, W. Zhang, O. Elkayal, V. Caubergs, J. Wauters, S. Desmet, E. Dreesen, I. Spriet	
	
Population pharmacokinetic modelling of colistin in critically-ill patients on sustained low-efficiency dialysis: implications for dose selection D. Fuhs* (Parkville, Australia), A. Boonyasiri, T. Naorungroj, L. Wang, J. Wang, R. Ratanarat, J. Li, R. Nation, T. Visanu, C. Landersdorfer	
	
2-hour Symposium Endoscopy: infection risks and mitigation	Chairs Elisabeth Presterl (Vienna, Austria) Gordon Ramage (Glasgow, United Kingdom)
	
Should we be concerned about infection from contaminated endoscopes?	Claire Aumeran (Clermont-Ferrand, France)
	
Prevention of multidrug-resistant infections from contaminated duodenoscopes Margreet C. Vos (Rotterdam, Netherlands)	
	
Understanding the causes of medical device contamination: it is all biofilm! Roberto Rusconi (Milan, Italy)	
	
Does the European medical Device Regulation bring us safer duodenoscopes?	Markus Hell (Salzburg, Austria) Co-organised with: ESCMID Study Group for Biofilms (ESGB), ESCMID Study Group for Nosocomial Infections (ESGNI) ESCMID Global 2025 - Programme
	
2-hour Oral Session Translating metagenomics into clinical practice	Chairs Benjamin Peter Howden (Parkville (Victoria), Australia) Paula Mölling (Örebro, Sweden)
	
Nanopore metagenomic sequencing for rapid bloodstream infection diagnostics evaluated in a prospective observational study H.L. Nielsen* (Aalborg, Denmark), C. Thygesen, K.K. Søgaard, A.B. Sørensen, S.M. Karst, A.L. Krarup, M. Albertsen	
	
Interpretative Criteria for Adjudicating Clinical Significance to Next-Generation Sequencing Results from Bronchial-alveolar Lavage and Bronchial Wash. J. Alexander* (Orlando, United States), A. Charles	
	
Implementing same-day respiratory metagenomic diagnostics in paediatric intensive care R. Hammond* (London, United Kingdom), A. Kopec, J. Brown, J. Hatcher, A. Alcolea-Medina, R. Batra, D. Ward, L.B. Snell, J. Breuer	
	
Detection of pathogenic microorganisms using metagenomic next-generation sequencing in ICU patients with ongoing antibiotic therapy T. Schroeder* (Nuertingen, Germany), M. Eliwi Alsaffan, A. Dervishi, P. Kawaletz, H. Stäudle	
	
Analysis of metagenomic pathogen detection compared to conventional diagnostics: clinical usage and relevance for patient outcomes E. Siegel* (Mainz, Germany), V. Bianco-Wilhelmi, S. Koch, C. Seckert, C. Hamm, D. Teschner, O. Kriege, D. Grimm, I. Sagoschen, D. Schreiner, M. Bodenstein, G. Cakas, S. Hagge, S. Vieira-Silva, T. Sparwasser	
	
Same-day pan-microbial metagenomics for personalized therapy and pathogen surveillance on the intensive care unit: a single-centre prospective study L.B. Snell* (London, United Kingdom), A. Alcolea-Medina, G. Humayun, N. Al-Yaakoubi, D. Ward, C. Alder, V. Patel, F. Vivian, C. Meadows, W. Duncan, R. Paul, N. Barrett, R. Batra, J. Edgeworth, J. Whitehorn, G. Nebbia	
	
Evaluation of the diagnostic efficacy of targeted next- generation sequencing in the detection of pathogens in bronchoalveolar lavage fluid from patients with lower respiratory tract infections in ICU B. Ran* (Taiyuan, China), Y. Liu, X. Wu, X. Lin, X. Li, Q. Zhan, C. Wang, L. Huang, T. Zhai, Y. Cai, Y. Song, Q. Zhang, C. Zhang, J. Hao, L. Jin, Z. Huang	
	
Prognostic and diagnostic value of Next-generation sequencing in female reproductive tract infection and HPV persistence C. Peng* (Shiyan, China), S. Qi, C. Jiachang, P. Chunyan, W. Taiquan, X. Xianru, Y. Jianying, Y. Qirong, Z. Pengyuan, L. Jun	
	
A promising approach to rapid, non-culture diagnosis of invasive fungal infections (IFIs) by targeted next- generation sequencing (tNGS) M.H. Nguyen* (Pittsburgh, United States), H. Badrane, B.A. Stevens, S. Cheng, G. Guigon, E. Santiago, M. Rambaud, B. Hao, E. Driscoll, W. Maynard, C. Clancy	
	
Implementation of Clinical Metagenomics in France: Insights from a Five-Years Study M. Dutkiewicz* (Paris, France), T. Ghelfenstein-Ferreira, L. Feghoul, S. Mercier-Delarue, A. Senhaji, A.L. Munier, F. Caméléna, J. Le Goff, M. Salmona	
	
2-hour Symposium Barriers to TB/HIV elimination in low- and high-incidence settings	Chair Daria Podlekareva (Copenhagen, Denmark)
	
HIV and TB epidemic: the storm hasn’t subsided yet Tetiana Koval (Poltava, Ukraine)	
	
Approaches for latent and active TB screening in people living with HIV Raimonda Matulionyte (Vilnius, Lithuania)	
	
Integration of HIV and TB care to improve patient outcome in resource-limited settings Akaki Abutidze (Tbilisi, Georgia)	
	
How researchers can influence policy and practice in HIV/TB care Jens D. Lundgren (Copenhagen, Denmark) Co-organised with: ESCMID Study Group for Mycobacterial Infections (ESGMYC), Euroguidelines in Central and Eastern Europe Network Group	
	
Educational Session RSV infections: diagnosis, surveillance and treatment in the advent of vaccines	Chair Monika Redlberger-Fritz (Vienna, Austria)
	
Costs of RSV infection, compared to other respiratory viruses Barbara Rath (Besançon, France)	
	
Virology and host interactions of RSV	
	
RSV surveillance in the EU/EEA in the vaccine era Eeva Broberg (Solna, Sweden)	
	
RSV fusion inhibitors and monoclonals: current status and future developments Peter Openshaw (London, United Kingdom) Co-organised with: ESCMID Study Group for Respiratory Viruses (ESGREV), International Society for Influenza and other Respiratory Viruses (ISIRV)	
	
Educational Session Traumatic wound infections: diagnosis and treatment options	Chairs Amparo Fernández-Rodríguez (Madrid, Spain) Veroniek Saegeman (Sint-Niklaas, Belgium)
	
Multidrug-resistant infections after trauma in warzone Shehan Hettiaratchy (Hampton, United Kingdom)	
	
Fungal infections during natural disasters Anuradha Chowdhary (New Delhi, India)	
	
Bacteriophage therapy for multidrug-resistant wound infections in trauma Tristan Ferry (Lyon, France)	
	
Infection of burn wounds Nur Benzonana (Istanbul, Türkiye) Co-organised with: ESCMID Study Group for Forensic and Postmortem Microbiology (ESGFOR), ESCMID Study Group for Non-traditional Antibacterial Therapy (ESGNTA), SEIMC (Sociedad Española Enfermedades Infecciosas Microbiología Clinica), International Society of Antimicrobial Chemotherapy (ISAC)	
	
2-hour Symposium Unveiling the challenges: nosocomial infections in ECMO-supported patients	Chairs Antonios Katsounas (Bochum, Germany) Jordi Riera (Barcelona, Spain)
	
Source of infection and pathogens Christian Eckmann (Hannover, Germany)	
	
Prophylaxis and empiric treatment Giacomo Grasselli (Besana In Brianza, Italy)	
	
Diagnostic criteria and definitions Graeme Maclaren (Singapore, Singapore)	
	
Microbial films Marta Hernández-Meneses (Barcelona, Spain) Co-organised with: European Extracorporeal Life Support Organization (EuroELSO) ESCMID Global 2025 - Programme	
	
Educational Session Are urinary tract infections still the same?	Chairs Suzanne Geerlings (Amsterdam, Netherlands) Agnes Maria Sonnevend (Pécs, Hungary)
	
Update on paediatric UTI Michael Buettcher (Luzern, Switzerland)	
	
Diagnosis and treatment of UTI in the era of antimicrobial resistance Jennifer Kranz (Aachen, Germany)	
	
Can UTI be prevented?	Chris Harding (Newcastle Upon Tyne, United Kingdom)
	
Fungal and parasitic infections of the urinary tract Gladys Mbwanji (Mwanza, Tanzania, United republic of)	
	
Educational Session OPAT: from aged wine to new vintage	Chairs Birgit Koch (Rotterdam, Netherlands) Sonia Luque (Barcelona, Spain)
	
OPAT: principles, practice and checklists Charlotte Quintens (Leuven, Belgium)	
	
COPAT: complex outpatient parenteral antimicrobial therapy Ronald Andrew Seaton (Glasgow, United Kingdom)	
	
Antimicrobial stability and other challenges for OPAT practice?	Mark Gilchrist (London, United Kingdom)
	
New OPAT safety and efficacy data to guide practice Matthew Rawlins (Murdoch, Australia) Co-organised with: ESCMID PK/PD of Anti-Infectives Study Group (EPASG), Society of Infectious Diseases Pharmacists (SIDP)	
	
Educational Session EUCAST Educational Workshop	Chairs Marlene Amara (Le Chesnay Cedex, France) Alasdair P. Macgowan (Bristol, United Kingdom)
	
EUCAST update Sören G. Gatermann (Bochum, Germany)	
	
Setting clinical breakpoints, assessing evidence Anouk Edwina Muller (The Hague, Netherlands)	
	
Benzylpenicillin susceptibility testing of S. pneumoniae by disk diffusion Gunnar Kahlmeter (Tävelsås, Sweden)	
	
What to do when there are no breakpoints Barbara Juliane Holzknecht (Copenhagen, Denmark)	
	
Detection of resistance mechanisms Christian Giske (Stockholm, Sweden) Co-organised with: EUCAST Steering Committee	
	
2-hour Oral Session One Health means resistance everywhere	Chairs Alessandra Carattoli (Rome, Italy) Prasannakumar Palanikumar (Vellore, India)
	
Decoding the role of bla CPE- carrying plasmids on wings: A holistic view using the One Health approach S.A. Martínez-Álvarez* (Logrono, Spain), P. Châtre, T. Cardona-Cabrera, P. François, U. Höfle, M. Zarazaga, J.Y. Madec, M. Haenni, C. Torres	
	
A novel isolation room model leveraging culture- independent Hi-C metagenomics for tracking antimicrobial resistance transmission between patients and hospital environmental reservoirs V. Koh* (Singapore, Singapore), R. Cabrera, J. Chua, J.S. Lee, N.S.B. Haidi Fitri, Z.X. Tan, X. Huan, N.M. Thevasagayam, T.K.B. Lee, K. Marimuthu, O.T. Ng	
	
Deciphering the pathogenic potentials and epidemiological identities of Staphylococcus pseudintermedius colonizing companion dogs in Sao Paulo I.B. Moses* (Sao Paulo, Brazil), L. Sartori, D.A. Henriques, M.M. Marini, F.M. Lima, R.X. Espinosa, I. Orlandino Da Silva, F.F. Santos, L. Gonzaga, A.T. Ribeiro De Vasconcelos, A.C. Gales	
	
Recent progress towards integrated surveillance of antimicrobial resistance in France L. Collineau* (Lyon, France), S. Bareille, G. Birgand, L. Lacmago, B. Lange, O. Lemenand, C. Chauvin	
	
Exploring the plasmidome of 3rd generation cephalosporin-resistant Enterobacterales in wild birds: Insights into horizontal gene transfer and AMR dissemination B. Timmer* (Debrecen, Hungary), L. Miló, B. Koleszár, C. Freytag, Á. Lovas- Kiss, L. Laczkó, G. Kardos	
	
Emergence of mobile colistin resistance in Klebsiella at human-animal-environment interface in Bangladesh S. Rahman* (Oxford, United Kingdom), A. Pondit, J. Parkhill, S. Saha, S.M.R. Islam, P.I. Disha, S.A. Nasreen, M.A.K. Azad, T. Walsh, R. Farzana	
	
Unveiling the invisible: antimicrobial resistance genes and pathogenic microbial diversity in sewage of North India&#39;s largest industrial hub, A metagenomic perspective I. Singh* (Chandigarh, India), R. Sharma, A. Arora, B. Mohan, N. Taneja	
	
Culturomics as a tool for ONE HEALTH approach: Unveiling the role of unknown microorganisms as antibiotic resistance carriers in wastewater samples E. Ouranou* (Heraklion, Greece), A. Psaroulaki, D. Chochlakis, M. Malliarou, K. Tryfinopoulou, A. Ntoula, E. Intze, I. Lagouvardos	
	
One Health intervention impacts on antibiotic resistance in Denmark, England and Senegal: A mathematical model comparison G. Knight* (London, United Kingdom), R. Booton, J.V. Robotham, K. Aluzaite, D. Belay, J. Guitian, M. Dione, E. Emes	
	
Clinically important sequence types and resistance genes in Enterobacteriaceae from coastal environments and gulls V. Silva* (Lisbon, Portugal), M. Quintelas, M. Caniça, R. Rivière, P. Poeta, G. Igrejas	
	
2-hour Symposium New insights into Candida pathogenesis	Chairs Aleksandra Barac (Belgrade, Serbia) Joshua Nosanchuk (Bronx, United States)
	
Insights into the evolution of Candida under antifungal pressure Attila Gacser (Szeged, Hungary)	
	
How do Candida extracellular vesicles modify virulence during disease?	Leonardo Nimrichter (Rio De Janeiro, Brazil)
	
The commensal to pathogen transition: kind to killer Ilse D. Jacobsen (Jena, Germany)	
	
Fungal-bacterial interactions: who wins?	Rebecca Hall (Canterbury, United Kingdom) ESCMID Global 2025 - Programme
	
2-hour Symposium Single-cell approaches to dissect cellular phenotypic heterogeneity of bacterial pathogen populations.	Chairs Christian Stephan Lentz (Tromsø, Norway) Annelies Zinkernagel (Zurich, Switzerland)
	
Adaptive evolution and phenotypic heterogeneity of bacterial pathogens during infections Christoph Ernst (Cologne, Germany)	
	
Single-cell imaging and heterogeneity in antimicrobial resistance Stefano Pagliara (Exeter, United Kingdom)	
	
Single-cell RNAseq and heterogeneity in bacterial transcription Anna Kuchina (Seattle, United States)	
	
Dissecting the function of individual bacteria in their spatial context Knut Drescher (Basel, Switzerland)	
	
1-hour Symposium Year in infection control	Chairs Nico Tom Mutters (Bonn, Germany) Ermira Tartari (Msida, Malta)
	
Andrew James Stewardson (Melbourne, Victoria, Australia)	
	
Kalisvar Marimuthu (Singapore, Singapore)	
	
ePoster Flash Session It&#39;s all in the blood	Chair Colin R. Mackenzie (Neuss, Germany)
	
Limited delayed incubation of blood culture bottles has limited effect on yield and time-to-positivity L. Hardy* (Antwerp, Belgium), A.S. Heroes, E. Genbrugge, B. Gleeson, C. Ferreyra, T. Vermoesen, E. Corsmit, B. De Smet	
	
Unnecessary clinical interventions due to blood culture contamination in a large Canadian hospital network C. Hall* (Hamilton, Canada), C. Fuller, S. Ramondino, C. Main	
	
Utility of sigmoidal growth curve when no organisms are seen on Gram stain in positive blood cultures D. Crilly* (London, United Kingdom), A. Bapat, J. Youngs, G. Maloney, E. Drakes	
	
Clinical microbiology laboratory consultancy to optimize blood culture workflow: Analysis of results C. Magri* (Rome, Italy), C. Magrì, G. Menchinelli, D. Squitieri, B. Fiori, M. Cacaci, B. Posteraro, G. De Angelis, M. Sanguinetti	
	
Comparison of Syndromic Sepsis Panel and Standard Blood Culture Results: Contribution to Patient Management S. Buyukberber* (Ankara, Türkiye), S. Aydogan, B. Dinc, N. Coplu, S. Turan, S.S. Yakin, H. Dal, T. Kayan	
	
Predicting blood culture positivity using machine learning with complete blood and differential counts in a tertiary care hospital of Turkiye Ö. Türkmen Recen* (Izmir, Türkiye), M. Kıplapınar, H. Özdemir, S. Kurutepe, H. Gazi	
	
Performance of direct pathogen and -lactamase detection workflow using MALDI-TOF MS from positive blood culture specimens K. Kosai* (Nagasaki, Japan), Y. Kawamoto, K. Yanagihara	
	
Waiting for follow-up blood cultures is not always necessary for diagnosis of central line-associated bloodstream infections L. Van Balen* (Maastricht, Netherlands), R. Koeck	
	
Economic and health gains associated with the adoption of the 2-hour phenotypic antimicrobial susceptibility testing in patients with bloodstream infection in Europe C. Pina-Vaz* (Oporto, Portugal), F. Aragão, C. Palos, C. Mimoso, I. Neves, M.J. Janeiro, J.A. Paiva	
	
ePoster Flash Session Emerging developments in antifungal pharmacology	Chair Roger Brüggemann (Nijmegen, Netherlands)
	
NATURE-US: the natural history of antifungal failure in invasive candidiasis L. Ostrosky-Zeichner* (Houston, United States), P.G. Pappas, M.H. Miceli, A. Spec, C.Z. Grimes, F. Lewis, M. Mammadova, E. McKie, M. Middle, M. Kordalewska, D.S. Perlin, D.P. Kontoyiannis, O.A. Cornely, J. Vazquez, D. Angulo	
	
The antidepressant vortioxetine enhances resistance toward multiple azoles S. Rizzo* (Rome, Italy), M. Cacaci, V. Di Pilato, S. Di Bella, U. Albert, B. Posteraro, M. Sanguinetti, F. Bugli, R. Torelli	
	
Enhancing Isavuconazole Pharmacokinetics: A Comprehensive Population (PPK) Model from Three Phase 3 Trials and Covariate Exploration A. Desai* (Northbrook, United States), L. Kovanda	
	
Identification of efflux inhibitors for Candida albicans through a drug repurposing strategy D. Marques* (Lisbon, Portugal), S. Santos Costa, L. Rodrigues	
	
Clinical outcomes of micafungin 100 mg vs. 150 mg daily for the treatment of Candida auris fungemia J. Hou* (Chicago, Il, United States), Y. Wang, R. Burgos, L. Danziger, E. Drwiega	
	
Resolution of clinical signs in adults with invasive candidiasis and/or candidaemia treated with rezafungin or caspofungin: ReSTORE and STRIVE trial pooled analysis G.R. Thompson* (Davis, California, United States), A. Soriano, M. Bassetti, P.M. Honore, J. Vazquez, S. Dickerson, O.A. Cornely	
	
Ibrexafungerp is effective in treatment of patients with candidiasis, including candidaemia, caused by Candida auris : a multicentre, open-label study (CARES) M.H. Miceli* (Ann Arbor, United States), T.F. Patterson, D. Juneja, G.R. Thompson Ill, P. Vergidis, A. Spec, T.J. Walsh, D. Angulo, J. Breedt, N. Yaddanapudi, R.S. Siebert, E. McKie, F. Lewis, M. Middle, M. Hoenigl	
	
High-dose isavuconazole therapy is well-tolerated and significantly improves survival in a fruit fly model of invasive mucormycosis S. Wurster* (Houston, United States), N.D. Albert, N.P. Wiederhold, R.E. Lewis, D.P. Kontoyiannis	
	
Pharmacokinetics, pharmacodynamics, safety, and efficacy of innovative dosing schedules of liposomal amphotericin B for treatment of experimental invasive pulmonary aspergillosis in persistently neutropenic rabbits R. Petraitiene* (New York, United States), E. Naing, A. Garcia, V. Zigmantaite, R. Grigaleviciute, A. Pockevicius, M. Zimmerman, A.H. Groll, T.J. Walsh, V. Petraitis	
	
Open Forum HIV: a global ethical Conundrum	Chair Seif Al-Abri (Muscat, Oman)
	
HIV, from key population to general population: a Pandora&#39;s Box Syed Faisal Mahmood (Karachi, Pakistan)	
	
Ethical considerations in preventing mother-to-child HIV transmission Glory Alexander (Bangalore, India)	
	
HIV drug trials in Africa: ethical concerns Shah Reena (Nairobi, Kenya)	
	
HIV-related stigma and discrimination in the healthcare setting Teymur Noori (Stockholm, Sweden) Co-organised with: ESCMID Ethics Advisory Committee (EEAC)	
	
ePoster Flash Session Infection control and prevention around the World	Chair Divyashree Shanthamurthy (Mumbai, India)
	
WHO Global Survey on Infection Prevention and Control Minimum Requirements: Laying the Foundation for 2030 Global Targets P. Bischoff* (Geneva, Switzerland), S. Tomczyk, G. Satta, E. Tartari, A. Meinen, P. Rogers, L. Cihambanya, C.R. Ana Paula, I. Hewedy, Z. Li, P. Ramon-Pardo, A. Singh, B. Allegranzi	
	
Healthcare-associated infections in african intensive care units: A muliticentre prospective cohort study B. Gaye* (Dakar, Senegal), N. Madani, J. Ben Khlil, A. Ben Souissi, B. Seydina Alouine, G.F. Otiobanda, R.M. Hamidi, M.S. Chaibou, P.A. Leye, L. Oualili, T. Dendane, K. Abidi, M. Bouaziz, R. Ammar, M. Elombila, W. Naija, M. Kahloul, R. Herch, R. Toumi, E. Ennouri, M. Boussarsar, N. Ben Mrad, A. Soumare, T.M. Diop, N. Brahmi, A. Ben Jazia, H. Ben Ghezala, A.A. Messadi, H. Fredj, A. Mokline, S. Abdellatif, T. Badis, L. Messaoud, A. Bouzid, S. Feki, H. Cheikhrouhou, A. Hachimi, B. Khemlich, F.Y. Bah, A.B. Faye, L. Ouanes Besbes, Z. Hammouda, M.S. Mebazaa, S. Elatrous, S. Ayed, W. Sellami, A. Ben Amri, M. Ferjani, O. Bouhamed, N. Hajjem, H. Daddy, M. Gagara Mayaou, B. Marou Soumana, B. Diallo, B. Gafsi, F. Ben Salem, E. Milli, B. Idali, T. Merhabene, N. Ben Slimane, F. Kaaniche Medhioub, R. Allala, C. Kaddour, N. Baffoun, R. Hammami, H. Allouche, H. Ghadhoune, S. Soui, H. Hmouda, R. Ben Dabebiss, A. Sidibe, N. Diani, N. Benmouhoub, M.S. Ado Zakari, O. Mamane Nassirou, O. Bachar Loukoumi, A. Ben Fraj, H. Jaoua, K. Ben Fadhl, T. Abdoulaye, T. Bagouma, H. Arfaoui, O. Kaabachi, O. Nasri, C. Ben Massoud, M. Niandou, M. Nanzir Sanoussi, H. Bassama, A. Jebri, H. Ben Fradj, A. Hafyene, N. Soraa, O. Kechini, A. Felhi, R. Abouqal, Y. Coulibaly	
	
Epidemiology of community-acquired versus hospital-acquired sepsis in acute hospitals in Ireland - 2016-2022. E. Liddy* (Dublin, Ireland), A. Vellinga, D. Amin	
	
Epidemiology of Central Line-Associated Bloodstream Infections (CLABSIs) in a Network of Ten Hospitals across Greece: A 30-Month Surveillance Study – GRIPP-SNF Network I. Kopsidas* (Neo Psychiko, Greece), E. Kourkouni, G.C. Tsopela, D. Kousi, A. Moutou, P. Varda, P. Pantelidou, A. Karaiiskou, D. Kaitelidou, T. Zaoutis, A. Koutsoukou	
	
Characterisation of plasmids disseminating antibiotic resistance in Klebsiella pneumoniae isolates from Pretoria, South Africa T. Govender* (Pretoria, South Africa), A. Moultrie, M. Moodley, J. Featherston, M. Mohlamonyane, J. Pitout, T. Hamiwe, T. Lentswe, S. Liknaitzky, K. Salvador-Oke, A. Smith, I. Arshad, M. Said, M. Ehlers, M. Kock	
	
Transmission dynamics of carbapenemase- producing bacteria between hospital and household settings in Benin K. Sintondji* (Abomey-Calavi, Benin), V. Dougnon, B. Legba, B.G. Hougbenou, K. Fabiyi, H. Koudokpon, A. Dalsgaard, Y.M.G. Hounmanou	
	
Evaluating the impact of a rapid screening test for carbapenem-resistant organisms in Brazilian intensive care units. M. Salomão* (Sao Paulo Sp, Brazil), B. De Almeida Lessa Castro, C. Loredana P. A. M. Bezerra, E. Lino Dos Santos Junior, C. Lee Luna Fernandes, A. Pereira Funari, S. Bollinger, F. C. Lessa, G. Mahon, M. Westercamp, M. Chiarastelli Salomao	
	
Genomic Insights into the Rapid Rise of Pseudomonas aeruginosa ST463: A High-Risk Clone&#39;s Adaptive Strategy in China X. Dong*	
	
Nanopore long-read only genome assembly for public health surveillance of Enterobacterales bloodstream infections and plasmid epidemiology in England: A pilot study D. Nagy* (Oxford, United Kingdom), N. Stoesser, S. Lipworth, V. Pennetta, G. Rodger, K. Hopkins, C. Jones, T. Neksus Study Group, S. Hopkins, D. Crook, A.S. Walker, J. Robotham, K.L. Hopkins, A. Ledda, D. Williams, R. Hope, C.S. Brown	
	
ePoster Flash Session Advances in the diagnosis and treatment of skin, bone, and joint infections	Chair Norma Jung (Köln, Germany)
	
Potential benefits of PET-CT in the management of bone and joint infections in infective endocarditis: a retrospective analysis from the Mayo Clinic F. Petri* (Milan, Italy), F. Borgonovo, O.K. Mahmoud, R. Igwilo-Alaneme, T. Matsuo, S. El Zein, D. De Simone, A. Gori, E. Berbari	
	
Synovial fluid microRNA biomarkers enable accurate diagnosis of periprosthetic joint infection B.J.H. Frank* (Vienna, Austria), T. Krammer, J. Pfeiffer-Vogel, T. Nguyen, A. Diendorfer, M. Hackl, J. Hofstaetter	
	
Diagnostic accuracy of 16S rDNA PCR, multiplex PCR and metagenomic Next-Generation Sequencing in periprosthetic joint infections: a systematic review and meta-analysis F. Olearo* (Hamburg, Germany), S. El Zein, E. Portillo M, A. Zapf, H. Rohde, E.F. Berbari, M. Wouthuyzen-Bakker	
	
Comparison of microbiology, management and outcome between patients with native and with post-surgical vertebral osteomyelitis: a 7-year retrospective study G. Franceschi* (Modena, Italy), M. Pellegrino, M. Del Monte, A. Bedini, L. Benassi, A. Soffritti, A. Tili, E. Dema, M. Palmisani, A. Veroni, G. Pavesi, M. Cristina	
	
Cefiderocol real-life use in bone and joint infection: a retrospective French multicenter study A. Diarra* (Tourcoing, France), V. Delastours, A. Bleibtreu, H. Wille, N. Sayre, N. Rouzic, K. Jaffal, I. Strachinaru, B. Valentin, M. Bermejo, P. Gazeau, A. Baldolli, B. Lefevre, A. Asquier, J. Courjon, R. Larcher, L. Escaut, L. Deconinck, N. Taar, V. Dacquet, T. Ferry, I. Eberl, M. Degrendel, P. Patoz, P.Y. Tortai, O. Robineau, E. Senneville	
	
Real-Life Experience with Dalbavancin as Suppressive Antibiotic Treatment in orthopaedic implant-related infections. R. Escudero-Sánchez* (Madrid, Spain), S. De La Villa Martínez, A. Rico Nieto, M. Sanchez-Somolinos, M. Tasias Pitarch, M. Salaver Lletí, M. Correa Ballester, R. Blanez Hernández, E. Calabuig Muñoz, M. Montero Alonso, L. Guio Carrion, J. Gomez Junyent, M.L. Sorli, F. Braojos Sanchez, A. Muñoz Gomez, M.J. Nuñez Oranto, E. Baos Muñoz, R. Manzano Lorenzo, J. Perez-Somarribas Moreno, J.M. Barbero Allende, M.J. Garcia Pais, F.J. Martínez Marco, A. Galeote Rivas, B. De La Torre Escuredo, J. Cobo	
	
Short or Long Antibiotic Regimes in Orthopaedics: the SOLARIO multicentre randomised controlled trial M. Dudareva* (Oxford, United Kingdom), M. Scarborough, M. Mcnally, M. Kumin, C. Scarborough, W. Vach, J. Ferguson	
	
Clinical and Antibacterial Diversity of Staphylococcal Phenotypes in Skin and Soft Tissue Infections: A Resource-Limited Country Perspective. F. Zeeshan* (Karachi, Pakistan), A. Naeem, F. Uddin	
	
Discrepancy between clinical-radiological diagnosis and surgical confirmation in 62 patients undergoing fasciotomy for suspected necrotizing fasciitis: a 11- year retrospective study. F. Romani* (Modena, Italy), A. Bedini, A. Spadoni, G. Manzini, G. Franceschi, B. Fontana, M. Sarti, C. Mussini	
	
ePoster Flash Session Rising threats: antimicrobial resistance in STIs	Chair Marcos Rust (Feldkirch, Austria)
	
Important rise of antibiotic resistance of Mycoplasma genitalium , a sexually transmitted pathogen, in a French University hospital F. Doucet Populaire* (Clamart, France), W. Ben Nejma, C. Benet, M. Grimaldi, I. Kansau, S. Pozzi-Gaudin, C. Guillet-Caruba, N. Bourgeois-Nicolaos	
	
Molecular characterization of antimicrobial resistance and genotyping of Mycoplasma genitalium positive samples of the Lisbon area, Portugal M. Barros* (Lisbon, Portugal), F. Pereira, L. Rodrigues	
	
Antimicrobial Resistance in Mycoplasma genitalium: Surveillance and Management in São Paulo, Brazil V. Passarelli* (São Paulo, Brazil), F. Goldemberg, A. Freitas, C. Picone, C. Lazari, G. Carnevale, M. Thomazella, S. Chamarelli, D. Gennari, C. Pedrozo, G. Hughes, S. Costa	
	
Impact of genotypic substitutions on treatment failure for Mycoplasma genitalium infection N.B. Bana* (Milan, Italy), A. Nava, D. Fanti, C. Vismara, G. Cavazza, E. Di Gennaro, F. Peracchi, L. Rezzonico, A. Mulè, L. Denti, M. Puoti, R. Rossotti	
	
Macrolide-resistant Mycoplasma genitalium : an emerging threat to public health?	J. Ciscar Soriano* (València, Spain), J. Ciscar-Soriano, M.D. Gómez- Ruiz, A. Valentín-Martín, A. Hernández-Cabezas, J.L. Lopez-Hontangas
	
Comparison of carbapenem MIC in wild-type, MDR and XDR Neisseria gonorrhoeae isolates J. Brousseau* (Paris, France), A. Braille, M. Mainardis, F. Meunier, M. Mérimèche, F. Caméléna, B. Berçot	
	
Unsettling surge in antimicrobial resistance patterns of Neisseria gonorrhoeae - A study from national reference centre in India. D. Sharma* (Delhi, India), S. Muralidhar, N. Joshi	
	
Surveillance of Neisseria gonorrhoeae antimicrobial resistance rate and treatment regimes in Singapore from 2014 to 2024 M. Giovanni* (Singapore, Singapore), A.L. Tan, B.K.W. Yeo, M.T.W. Chio, S.S. Goh, S.T. Koh, Y.E. Tan	
	
Molecular surveillance results of N. gonorrhoeae in Korea K.H. Roh* (Goyang, Korea, Republic of), C. Liu, Y.H. Suh, H. Lee, K. Lee	
	
Keynote Lecture Asia: an AMR Hot Zone	Chairs Giulia De Angelis (Rome, Italy) Robert Leo Skov (Copenhagen, Denmark)
	
David L. Paterson (Singapore, Singapore)	
	
1-hour Case Session Antimicrobial drugs in action	Chairs Katy Jeannot (Besançon, France) Timothy R. Walsh (Oxford, United Kingdom)
	
In vivo cefiderocol resistance due to cirA modification during treatment E. Carretto* (Reggio Emilia, Italy), P. Pini, R. Farzana, C. Bedogni, R. Marrollo, P. Nardini, M. Bardaro, N.C. Facciolongo, S. Mezzadri, T. Walsh	
	
Long-term outcomes in dalbavancin-treated patients with vascular graft infection. A. Specklin* (Reims,	
	
Aztreonam, ceftazidime/avibactam, and tigecycline combination for the management of multi-drug resistant E.coli on peritonitis in a pediatric liver transplant recipient R. Morales Junior* (Cincinnati, United States), V. Juodinis, C. Donini, J. Sampaio	
	
Early oral antibiotic treatment in patients with post- neurosurgical brain abscesses caused by Cutibacterium acnes – a case series M. Karolyi* (Vienna, Austria), D. Stahl, E. Pawelka, S. Omid, A. Kuran, M. Naegeli, A. Zoufaly, C. Well, S. Fischoeder, M. Ortler, C. Wenisch	
	
Meropenem-vaborbactam as intrathecal-sparing therapy for the treatment of carbapenem-resistant K. pneumoniae shunt-related ventriculitis: two case reports. G. Giuliano* (Siena, Italy), M. Sambo, P. Castellani, S. Benedetti, F. Tarantino, M. Tumbarello	
	
1-hour Symposium How long should contact isolation precautions be continued?	Chairs Cansu Cimen (Oldenburg, Germany) Kyriaki Tryfinopoulou (Heraklion, Greece)
	
Contact isolation in patients with MDR organisms: Why, when, where?	Gabriel Birgand (Nantes, France)
	
Is discontinuation of contact precautions associated with an increase in infections?	Daniel Diekema (Harpswell, United States) Co-organised with: ESCMID Study Group for Nosocomial Infections (ESGNI), EUCIC Steering Committee, Multidisciplinary Joint Committee Infection Control UEMS
	
Meet-the-Expert Cut a long story short: choosing NGS platforms	
	
Etienne Ruppe (Paris, France)	
	
Stefan Green (Chicago, United States)	
	
1-hour Oral Session Around the lab in 80 ways: a journey through innovative therapeutics	Chairs Zuzanna Drulis-Kawa (Wroclaw, Poland) Helena Zemlickova (Prague, Czech Republic)
	
In vivo expression of an mRNA encoded multi- mechanistic mAb combination against Staphylococcus aureus and protection in a disease model C. Tkaczyk* (Gaithersburg, United States), N. Michael, P. Mun Mun, T. George, S. Martin, G. Adam, M. Andal, D. Julie, S. Oleg, B. Elin, Y. Haitao, E. Mark, L. Ashley, D. Antonio, S. Bret	
	
Hijacking intrinsic resistance in Mycobacterium abscessus G. Phelps* (Memphis, United States), S. Kurt, A. Jenner, S. Anderson, T. Jayasinghe, E. Griffith, C. Thompson, L. Yang, B. Wicki, F. Bright, L. Boeck, V. Loudon, R. Lee, A. Wright, W. Wright, O. Grant-Chapman, J. Ochoado, D. Conner, B. Troyer, A. Iverson, J.W. Rosch, B. Schulthess, P. Geeleher, S. Hobbie, B. Meibohm, A. Obregon-Henao, P. Sander, R. Lee	
	
Tripartite bacteriophage-based strategy to combat human clinical pathogens P. Kalatzis* (Copenhagen, Denmark), R. Ibarra-Chávez, H. Sampson, S. Michniewski, A. Shen, M. Ford, B. Petersen, P. Worning, P. Klement, H.P. Calum, U.M. Singh, A. Millard, M. Clokie, T. Sicheritz-Pontén	
	
Eosin Y and Ceragenin combinations for enhanced antimicrobial photodynamic therapy Y. Tekintas* (Cigli, Türkiye), P.B. Savage, M. Ucuncu	
	
Identification of compounds capable of removing established bacterial biofilms T. Inzana* (Brookville, United States), A. Gates, W. Weng, J. Cusumano, Y.J. Lee, N. Vogelaar	
	
Meet-the-Expert How to perform clinical trials in mycoses?	
	
Monica Slavin (Melbourne, Australia)	
	
Nkechi Azie (Barrington, United States) Co-organised with: ESCMID Fungal Infection Study Group (EFISG)	
	
1-hour Oral Session Climate Impact and One Health Approaches Against Infectious Diseases	Chair Chadia Wannous (Paris, France)
	
Airborne Threats: Pollution, Climate, and Respiratory Infections in a Pyrenean setting: The Andorran hospital based respiratory perspective C. Royo- Cebrecos* (Andorra, Andorra), N. Duran Torralbo, D. Vilanova Gonzalez, M. Clusas Antolin, L. Trapero	
	
Effects of climate change on Aedes aegypti abundance and dengue transmission L. Geng* (Singapore, Singapore)	
	
Impact of climate variables on Crimean-Congo hemorrhagic fever in Iran, Iraq, Kazakhstan, and Russia M. Fereidouni* (Jahrom, Iran, Islamic Republic of), D. Bisanzio, I. Lizinfeld, N. Pshenichnaya, G. Abuova, M.R. Shirzadi, H. Abdulghafoor Khaleel, R. Alhilfi, M. Keshtkar-Jahromi	
	
Successful public health and one health response to a high pathogenicity avian influenza outbreak in poultry farms in Victoria, Australia: implications for future planning E. Athan* (Geelong, Australia), A. Hussain, K. Blaney, L. Cardamone, N. Clarke, M. Hayes, M. Muleme, B. Mcnamara, E. Jalil, S. Holwill, C.K. Lim, H. O&#39;brien, E. Layton, A. Fidao, S. Salmon, R. Kinnear	
	
Turning disease surveillance into reality: Using metagenomic sequencing with piggery wastewater M. Muralidhar* (St Lucia, Australia), L. Omaleki, M.N. Naseem, J.R.B. Mesa, C. Turni	
	
1-hour Oral Session Viral challenges in organ transplantation	Chairs Ghady Haidar (Pittsburgh, United States) Cristiana Oprea (Bucharest, Romania)
	
Evaluation of an individualized CMV prevention strategy guided by post-transplant CMV-specific cell- mediated immunity in intermediate-risk kidney transplant recipients I. Rodríguez-Goncer* (Madrid, Spain), J.M. Caso, M. Fernández-Ruiz, E. González, N. Polanco, N. Redondo, T. Ruiz-Merlo, R. San-Juan, L.M. Allende, E. Paz-Artal, A. Andrés, F. López- Medrano, J.M. Aguado, I. Rodríguez-Góncer	
	
Real-world Use of Letermovir Prophylaxis for Cytomegalovirus (CMV) Prevention in Non-kidney Transplant Recipients A. Mughrabi* (Rochester, Minnesota, United States), B. Bisono-Garcia, S. Chesdachai, N. Ranganath, R. Razonable	
	
Real-world administration of maribavir beyond the eight weeks established in the clinical trial D. Martínez-Simón* (Barcelona, Spain), C. Ribera-Puig, M. Bodro, D. Campany, J. Esperalba, I. Los Arcos, P. Clèries-Rovira, A. Padullés, N. Sabé Fernández, M. Tuset, O. Len	
	
Prediction of BK Polyomavirus nephropathy in kidney transplantation by measuring neutralizing responses in a large cohort of donor and recipients M. Solis* (Strasbourg, France), W. Fardi, I. Benotmane, F. Gallais, S. Caillard, S. Fafi-Kremer	
	
Dengue in solid organ transplant recipients S.I. Galian* (Buenos Aires, Argentina), N. Pujato, N.S. Nolis, R. Del Grosso, P. Lopez, G. Aballay, M. Agustin, G. Werber	
	
1-hour Symposium What happens following TB infection?	Chairs Catherine Ong (Singapore, Singapore) Sean Wasserman (London, United Kingdom)
	
Post-TB disease: burden and treatment strategies Deborah Chong (London, United Kingdom)	
	
TB sequelae and fungal infection Helmut Salzer (Linz, Austria) Co-organised with: ESCMID Study Group for Mycobacterial Infections (ESGMYC), CPAnet YIA 11:00 - 12:00 Hall 3 Awards Young Investigator Award Session	
	
Deciphering the pathogenic traits and epidemiological identities of Staphylococcus pseudintermedius : an emerging and underestimated zoonotic pathogen Ikechukwu Benjamin Moses (Abakaliki, Nigeria)	
	
Drugs for Vector-borne Infections: Facts and Fibrillations Xin Hui Chan (Oxford, United Kingdom)	
	
Duke criteria for the diagnosis of infective endocarditis in clinical practice: are we there yet?	Matthaios Papadimitriou Olivgeris (Sion, Switzerland)
	
Finding a place for observational studies in infectious diseases research Anthony Bai (Kingston, Canada)	
	
Clearing fungal fog in viral storms: deciphering influenza- and COVID-19-associated pulmonary aspergillosis Simon Feys (Leuven, Belgium)	
	
1-hour Symposium New frontiers in bacterial pathogenesis	Chairs Silvio Daniel Brugger (Zurich, Switzerland) Abdou Hachani (Melbourne, Australia)
	
Bacterial infections and cellular immunity Charlotte Odendall (London, United Kingdom)	
	
Immuno-metabolism in bacterial diseases Tania Wong (New York, United States)	
	
1-hour Oral Session New developements in prophylaxis and treatment of COVID-19	Chairs Gülsen Özkaya Sahin (Lund, Sweden) Snjezana Zidovec Lepej (Zagreb, Croatia)
	
Ensitrelvir for the prevention of COVID-19 among household contacts: key subgroup analyses of a randomized, double-blinded, placebo controlled post-exposure prophylaxis study, SCORPIO-PEP F. Hayden* (Virginia, United States), N. Ohmagari, T.W. Clark, M. Shinkai, A.F. Luetkemeyer, P. Sax, W.P. Hanage, K.A. Gebo, H. Ikematsu, K. Izumikawa, C.C. Butler, A. Fukushi, S. Kezbor, H. Sakaguchi, S. Lacey, G. Ichihashi, T. Uehara	
	
Efficacy of nirmatrelvir/ritonavir on overall COVID- 19 related symptoms in immunocompromised adult participants from the EPIC-IC trial R. Mokgokong* (Tadworth, United Kingdom), P. Cislo, E. Tudone, E. Weinstein, J.C. Cappelleri	
	
COVID-19 patients benefitting from remdesivir for improved survival: a neural network-based approach. T.F. Aiello* (Barcelona, Spain), C. Teijón- Lumbreras, C. Garcia-Vidal, M. Chumbita, M. Rosario, A. Mateu Subirà, O. Peyrony, P. Monzó- Gallo, A. Gallardo-Pizarro, A. Martinez-Urrea, R. Méndez, E. Calbo, M. Ballestero-Tellez, G. Cuesta- Chasco, M. Marcos, A. Soriano	
	
Efficacy and safety of sotrovimab vs oral antivirals in omicron waves: a retrospective analysisC. Cacace* (Napoli, Italy), A. Russo, M. Pisaturo, P. Grimaldi, F. Ambrisi, G. Granata, F.G. Numis, N. Coppola	
	
Pharmacokinetics and immunogenicity of AZD7442 (Tixagevimab/Cilgavimab) in hospitalised COVID-19 patients: results from the DisCoVeRy trial C. Massonnaud* (Paris, France), M. Hites, N. Peiffer- Smadja, T.H.L. Han, G. Carcelain, F. Mentré, F. Ader	
	
1-hour Oral Session Advancing Malaria Research: From Molecular Insights to Clinical Challenges	Chairs Kamruddin Ahmed (Kota Kinabalu, Malaysia) Giri Shan Rajahram (Kota Kinabalu, Malaysia)
	
Influence of second blood meals on Plasmodium vivax development and infectivity in mosquitoes S. Bantuchai* (Bangkok, Thailand), W. Nguitragool, J. Sattabongkot, C. Kumpitak	
	
Severe imported Plasmodium falciparum malaria with hyperparasitaemia: evaluation of predictors for critical disease T. Lingscheid* (Berlin, Germany), J. Jochum, P. Tober-Lau, J. Schöllgen, T. Zoller, L.E. Sander, M. Ramharter, F. Kurth	
	
The current status of Plasmodium falciparum chloroquine resistance transporter gene (K76T) and Plasmodium falciparum multi-drug resistance gene 1 (N86Y) in Cameroon M. Fru* (Buea, Cameroon)	
	
SOFA score vs WHO severity criteria to guide antimalarial treatment - 10 years of imported malaria cases in a UK tertiary centre reviewed. E. Savory* (Cambridge, United Kingdom), M. Routledge, B. Warne, E. Moore, D. Sparkes	
	
1-hour Case Session Osteoarticular uninvited guests	Chairs Tiziana Ascione (Naples, Italy) Jaime Esteban (Madrid, Spain)
	
Antibiotic-refractory oligoarthritis in an adolescent caused by Borrelia bavariensis in Croatia N. Krajcar* (Zagreb, Croatia), L. Stemberger Marić, M. Vrdoljak Pažur, S. Roglić, R. Beck, G. Tešović	
	
Progression of vertebral echinococcosis despite radiotherapy treatment M. González-Sanz* (Madrid, Spain), O. Martín, A. Romero-Alegría, M. Belhassen, S. Chamorro Tojeiro, D. Gayoso Cantero, F. Norman, B. Monge Maillo, C. Crespillo-Andújar, M.D. Corbacho-Loarte, S. De La Fuente-Herranz, J. Cobo Soriano, J. Urbano, M. Martín Martín, J.A. Pérez- Molina	
	
Two cases of septic osteoarthritis of Cutibacterium acnes detected by 16S rRNA gene sequencing in immunocompetent adolescents H. Okuno* (Osaka, Japan), K. Shiota, K. Amo	
	
A UK case of Melioidosis with osteomyelitis two years after geographical exposure C. Darlow* (Liverpool, United Kingdom), L. Swithenbank, R. Taggart, V. Owen, N. Wong, S. Woolley, W.D. Harrison, L. Ratcliffe, J. Lewis	
	
When Infection Masquerades as Malignancy: A Case of Disseminated Mycobacterium fortuitum complex infection with Mixed Osteoblastic and Osteolytic Lesions and Lymphadenopathy in Anti-IFN- Immunodeficiency Syndrome N. Hiranburana* (Bangkok, Thailand), S. Khahakaew, K. Meesilpavikkai, M. Satja, G. Suwanpimolkul	
	
1-hour Oral Session Advances in vaccine effectiveness for viral respiratory infections	Chair Jean Paul Stahl (Corenc, France)
	
Immunogenicity of JN.1- and KP.2-encoding mRNA COVID-19 vaccines against JN.1 SARS-CoV-2 sublineages in adult participants A. Figueroa* (Cambridge, United States), D. Edwards, K. Johnson, D. Motefiori, B. Girard, S. Hack, X. Cao, E. De Windt	
	
JN.1-adapted vaccine effectiveness against COVID-19 hospitalisation in Europe: a test-negative case-control study using id.DRIVE H.R. Volkman* (New York, United States), L. De Munter, J.L. Nguyen, T.M.P. Tran, C. Marques, E. Mesfun-Kap, L. Choi, L. Drikite, S. Valluri, J.V. Hernandez-Villena, J. Yang, I. Casas, E. Martro, B. Gruner, G. Icardi, A. Mira-Iglesias, C.M. Oñoro López, O. Pares-Badell, A. Orrico-Sanchez, S. Otero-Romero, A. Riva, A. Torres, F. Martinon Torres, L. Jodar, J.M. Mclaughlin, K. Bollaerts	
	
Real-world effectiveness of 20-valent pneumococcal conjugate vaccine among adults ≥65 years of age in the United States A. Miles* (New York, United States), J.T. Vietri, S. Rosenstock, H. Li, J. Vojicic, L.R. Grant, A. Randall, B.D. Gessner, P. Balmer, A. Cane, P. Peyrani	
	
Safety and immunogenicity of the MERS vaccine, ChAdOx1 MERS, in older adults with and without prior ChAdOx1 exposure D. Jenkin* (Oxford, United Kingdom), E. Sheehan, R. Huq, T. Lambe, S. Gilbert, A.M. Collins, M.N. Ramasamy, A. Mujati, R. Kenneil, N. Marchevsky, I. Haeusler, E. Vannaxay, N. Ebrahimi, S. Batawi, F. Cappuccini, R. White, L.S. Ortega, O. Mazur, H.T. Belhadef, B. Stoilova, D. Pulido-Gomez, H. Zhang, K. Conlin, M. Voysey, A. Hyder-Wright, L. Mclellan, O. Hamilton, V. Simpson, J. Court, N. Murphy, M. Farrar, P. Saunderson	
	
Vaccination in pregnancy with RSVpreF elicits IgG, IgA and total secretory antibody responses in milk of lactating individuals J. Atwell* (New York, United States), R. Powell, X. Yang, C. Decarlo, A. Fox, R. Fan, S. Uppal, J. Deese, M. Vichnin, E. Gonzalez, B. Gessner	
	
1-hour Symposium Year in infectious diseases	Chairs Nur Benzonana (Istanbul, Türkiye) Evelina Tacconelli (Verona, Italy)
	
Yoav Keynan (Winnipeg, Canada)	
	
Elisa Cordero Matia (Seville, Spain)	
	
1-hour Symposium Developing guidelines with AI tools: are they ready for prime time?	Chairs Miranda Langendam (Amsterdam, Netherlands) Blin Nagavci (Gjakove, Kosovo)
	
The PROs and CONs of using AI tools for developing guidelines Holger Schuenemann (Milano, Italy)	
	
AI in action: validated tools for speeding up your systematic reviews and how to use them Sara Fernandez (Oslo, Norway) Co-organised with: ESCMID Guidelines Subcommittee	
	
1-hour Symposium Exploring children&#39;s role in infection spread	Chairs Angelika Berger Sanjay Patel (Winchester, United Kingdom)
	
Are children really super-spreaders of respiratory viruses?	Emmanuel André (Leuven, Belgium)
	
Should schools be closed at the start of the next pandemic?	Vittoria Colizza (Paris, France) Co-organised with: European Society of Paedriatic Infectious Diseases (ESPID)
	
ePoster Flash Session Infections in hemato-oncological hosts: from bacterial to viral	Chair Genovefa Papanicolaou (New York, United States)
	
Vancomycin-resistant Enterococcus faecium bloodstream infection in patients with hematological malignancy and stem cell transplant: a case-control study J. Fung* (Vancouver, Canada), K. Aldhaheri, C. Nishi, J. Lau, A. Mah, A. Wright, R. Stubbins, M. Charles, S. Belga	
	
Bacteremia secondary to urinary tract infection in oncology patients: risk factors and impact of multidrug-resistant Gram-negative bacilli. I. Grafia* (Barcelona, Spain), A. Moll, S.J. Santillá, C. Rodrigo, E. Lillo, M. Garcia De Herreros, N. López, A. Soriano, M. Espasa, D. Marco, S. Fernández, J. Marco- Hernández, C. Zamora, J. Padrosa, L. Llavata, M. Viladot, A. Tuca, P. Puerta-Alcalde	
	
Rectal carriage of multidrug-resistant organisms and subsequent bloodstream infections in hematologic patients undergoing hematopoietic stem cell transplantation or chimeric antigen receptor T-cell therapy C. Charalampidis* (Athens, Greece), I. Konstantellos, P. Kazakou, K. Gkirkas, I. Lazana, C. Chatzidimitriou, A. Zormpa, E. Mastrostamati, I. Grigoropoulos, D. Kavatha, S. Tsiodras, P. Tsirigotis, K. Thomas	
	
The RUSTIC Study: Respiratory Virus Infection in a Contemporary Longitudinal Cohort of Patients with Haematological Malignancy B. Teh* (Melbourne, Australia), V.G. Hall, A. Liu, K.Y. Yong, Z. Andrews, P. Kinsella, N. Laundy, J. Wolfe, L. Cooley, M.K. Yong, M.A. Slavin	
	
Viral respiratory infections in patients with hematological diseases over 10 years: epidemiology and impact on disease severity P. Bono* (Milan, Italy), A. Parisi, E. Tagliaferri, R. Ungaro, G. Saporiti, F. Cavallaro, G. Bozzi, M.C. Goldaniga, G. Galli, N. Hejazifar, C. Biassoni, G. Giacomel, A. Valzano, M.R. Sciumè, N. Fracchiolla, A. Bandera, F. Passamonti, A. Callegaro, C. Alteri	
	
Safety and tolerability of SYN-004 in allogeneic hematopoietic cell transplant (HCT) recipients receiving meropenem (MER) or piperacillin/tazobactam (P/T) E. Dubberke* (Saint Louis, United States), M. Schroeder, H. Sappington, G. Lampen, K. Reske, T. Hink, V. Joachimstaler, E. Jeremy, M. Keller, A. Bristol, C. Le, S. Connelly, M. Moenk, V. Wacher, M. Kaleko, J. Kuti, M. Olsen	
	
Standardized gastrointestinal cytomegalovirus (CMV) tissue quantitative-nucleic-acid testing (QNAT) compared to immunohistochemistry in allogeneic hematopoietic cell transplant (HCT) recipients S. De Aragón De La Cruz* (Basel, Switzerland), C.S. Walti, N. Khanna, K. Leuzinger, J.P. Halter, H.H. Hirsch, K. Nägele, J. Passweg, J. Vosbeck	
	
Real-life experience with maribavir for the treatment of cytomegalovirus infection in hematological patients. J. Boan Perez* (Madrid, Spain), J.M. Sánchez-Pina, C. Aizpurúa, I. Rodríguez-Goncer, F. López-Medrano, R. San-Juan, M. Fernández-Ruiz, E. Aparicio, M. Lizasoaín, J.M. Caro-Teller, J. Martínez, M. Calbacho, J.M. Aguado	
	
ePoster Flash Session Syndromic testing is still coming of age	Chair Tommaso Giani (Florence, Italy)
	
Bacterial infections of the central nervous system: addressing the diagnostic gap in non- community- acquired meningitis G. Menchinelli* (Rome, Italy), M. Cacaci, D. Squitieri, B. Fiori, T. D&#39;inzeo, G. De Angelis, B. Posteraro, M. Sanguinetti	
	
Epidemiological surveillance of central nervous system infections through a rapid syndromic testing platform M. Rey* (Barcelona, Spain), L. Pau, C. Miravet, A. Molins, G. Hansen, M. Juanola-Falgarona	
	
Impact of Syndromic Panel Implementation on Meningitis/Encephalitis Diagnosis, Antimicrobial Use, Costs, and Hospital Stay in a Regional Australian Hospital S. Subedi* (Brisbane, Australia), P. Harris, D. Paterson	
	
Performance evaluation of the NxTAG® GPP Panel for the detection of gastrointestinal pathogens by comparison with current routine methods in Nantes University Hospital. S. Gibaud* (Nantes, France), L. Castain, S. Hartuis, C. Hervochon, B.M. Imbert, P. Lepape, S. Corvec	
	
Correct discrimination of Monkeypox virus clades by fast syndromic testing S. Reister* (Hilden, Germany), L. Peñarrubia, M. Juanola-Falgarona, G. Pueyo, S. Jiménez-Guzmán, R. Diaz-Hernández, E. Padilla- Cámara, J. Michel, A. Puyskens, F. Van Deursen, D. Lueerssen	
	
Managing a Mycoplasma pneumoniae Outbreak: Impact of Syndromic Panels on Antimicrobial Prescriptions in Pediatric Emergencies L. Brusca* (Barcelona, Spain), L. Brusca-Vidao, M. Pallarés- Borrás, G. Santillana-Cernuda, M. Ballestero-Tellez, A. Boronat, J. Perez	
	
Performance of BIOFIRE® FILMARRAY® Pneumonia plus in general population, solid organ transplant recipients and patients with hematologic malignancies – Interim analysis R. Riccardi* (Bologna, Italy), M. Rinaldi, G. Ceccarelli, C. Campoli, C. Tondi, M. Casarini, B. Miani, G. Nigrisoli, S. Ambretti, P. Viale, M. Giannella	
	
Impact of the molecular rapid diagnostic panel testing in adjustment of antimicrobial therapy in febrile neutropenic patients with bacteremia S. Chantharasut* (Bangkok, Thailand), M. Chayakulkeeree, W. Kamolvit, A. Jitmuang, I. Thaipisuttikul	
	
BacteREVEAL: Analytical performance and contribution of BioFire® BCID2 and Vitek® REVEAL TM in intensive care patients with Gram- negative bloodstream infections C. Roger* (Nimes, France), L. Oudiane, M. Benyahia, F. Salipante, A. Dubois, L. Muller, J.P. Lavigne, A. Pantel	
	
ePoster Flash Session Effective microbiology for the management of sepsis	Chair Maurizio Sanguinetti (Rome, Italy)
	
Molecular epidemiology of Klebsiella bloodstream infection-causing isolates across England using Nanopore longread-only sequencing: An interim analysis of the NEKSUS study D. Nagy* (Oxford, United Kingdom), N. Stoesser, S. Lipworth, V. Pennetta, K. Hopkins, G. Rodger, R. Moran, C. Jones, T. Neksus Study Group, S. Hopkins, D. Crook, A.S. Walker, J. Robotham, K.L. Hopkins, A. Ledda, D. Williams, R. Hope, C.S. Brown	
	
Investigating seasonality of antibiotic resistance associated with E. coli and Klebsiella pneumoniae bloodstream infections S. Lipworth* (Oxford, United Kingdom), L. Gorman, A. Dowsey, K. Pouwels, K. Sanderson, C. Beck, R. Hope, C. Brown, K. Turner	
	
Sensitivity of a host-protein test for microbiologically confirmed bacterial infections R. Navon* (Tirat Carmel, Israel), E. Reiner, O. Shaham, A. Neuberger, S. Shiber, S. Halabi, A. Epstein, T. Zalut, S. Motov, T.P. Aufderheide	
	
Comparative genomics of Klebsiella pneumoniae from gut colonisation and bloodstream infections reveal novel genetic associations M. Hetland* (Stavanger, Norway), K.L. Wyres, H.B. Cooper, A. Correia, M.A. Winkler, A. Fostervold, N. Raffelsberger, A. Sundsfjord, Ø. Samuelsen, K.E. Holt, I.H. Löhr	
	
Conventional microbiology vs. conventional microbiology + nucleic acid-based multiplex real-time polymerase chain reaction (MPCR) test kit in septic shock: results of a matched cohort study G. Sanlidag Isbilen* (Izmir, Türkiye), G. Şanlıdağ İşbi̇len, B. Akkul, C. Tol, D. Akyol Seyhan, H. Sipahi, Ş. Aydemir, F. Çilli, B. Arda, O.R. Sipahi	
	
Contribution of Escherichia coli microbiological factors to the presentation as sepsis/septic shock in patients with bacteraemia: a matched case-control study N. Maldonado* (Seville, Spain), I. López- Hernández, L.E. López-Cortes, P.M. Martínez Pérez- Crespo, A. García-Montaner, M. Alcade-Rico, A. Sousa-Dominguez, A. Jover-Sáenz, J. Goikoetxea, Á. Pulido-Navazo, C. Labayru Echeverría, A.I. Aller- García, L. Boix-Palop, A. Del Arco-Jiménez, A. Smithson-Amat, J.M. Sánchez-Calvo, C. Natera- Kindelán, J.M. Reguera Iglesias, C. Armiñanzas- Castillo, F. Galán-Sánchez, A. Bahamonde, I. Gea- Lázaro, J. Fernández-Suárez, I. Pérez-Camacho, T. Marrodán-Ciordia, B. Becerril-Carral, Á. Pascual- Hernández, J. Rodríguez-Baño	
	
Simplified and rapid bacterial identification with antimicrobial resistance detection in bacteremia by on-chip multiplexed LAMP. C. Treille* (Saclay, France), K. Perez-Toralla, H. Boutal, X. Garcia Velasquez, L. Pommies, S. Simon, H. Volland	
	
Community-onset bloodstream infection among people with opioid use disorders: A twenty-year population-based cohort study in Queensland, Australia. K. Laupland* (Herston, Australia), A. Stewart, F. Edwards, P. Harris, S. Coulter	
	
Microbiological diagnosis tools for primary and secondary abdominal aortic infections requiring surgery S. Soueges* (Lyon, France), A. Blanco, A. Souche, C. Triffault-Fillit, M. Arsicot, M. Wan, N. Della- Schiava, U. Huvelle, A. Millon, F. Valour	
	
ePoster Flash Session A never-ending evolution of antimicrobial resistance	Chair Antonio Oliver (Palma De Mallorca, Spain)
	
Gfa, a novel integron-born fosfomycin resistance mechanism N. Kieffer* (Madrid, Spain), L. Ortiz- Miravalles, A. Hipolito, J.A. Escudero	
	
Regulons of RamA, RarA and SoxS mediated tigecycline resistance and oxidative stress among in vitro tigecycline resistant evolution trajectory of Klebsiella pneumoniae . X. Wang* (Beijing, China), J. Kuai, Y. Zhao	
	
Assessing the impact of altered penicillin binding proteins on susceptibility to novel antimicrobials among clinical isolates of carbapenemase-producing Escherichia col C. Tellapragada* (Stockholm, Sweden), P. Jonsson, C. Giske	
	
Enterococcus faecalis penicillin-binding protein-4 sequence differences based on penicillin minimum inhibitory concentration O. Funk* (Brooklyn, United States), A. Kozlenkov, C. Toro Chacon, J. Azzouzi, S. Brown, J. Cusumano	
	
Uncommon genomic rearrangements drive vancomycin resistance in vanB -positive Enterococcus faeciumK. Xanthopoulou* (Cologne, Germany), J. Mellüh, R. Arazo Del Pino, L. Casselmann, V. Persy, T. Burgwinkel, E. Gieraths, L. Maus, A. Klimka, P.G. Higgins	
	
Heteroresistance in Enterococcus faecalis : prevalence and mechanistic insights across clinically relevant antibiotics S. Heidarian* (Uppsala, Sweden), S. Lohsen, A. Guliaev, K. Hjort, S. Satola, D. I. Andersson	
	
Side effects of rifampicin resistance: transcriptome modulation by rpoB mutations in Staphylococcus aureusM. Roch* (Geneva, Switzerland), R. Sierra, C. Colomer Winter, F. Bezrukov, O. Panasenko, A. Guisolon, U. Von Ah, M. Villanueva, P. Redder, K. Kline, J. Prados, W.L. Kelley	
	
Novel continuous experimental evolution methodology revealing rapid resistance development and cross-resistance T. Echelmeyer* (Greifswald, Germany), M. Ellmann, S.E. Heiden, M. Schwabe, H. Fickenscher, G. Maschkowitz, D. Nurjadi, R. Podschun, K. Schaufler, E. Eger	
	
1-hour Oral Session Battling the Spore: C. difficile epidemiology and management	Chairs Nicolas Benech (Lyon, France) Fidelma Fitzpatrick (Dublin, Ireland)
	
Molecular epidemiology and antimicrobial resistome of Clostridioides difficile from private and public healthcare settings in three provinces in South Africa H. Shirinda* (Pretoria, South Africa), A.M. Smith, B. Prinsloo, M. Kock, M. Moodley, M. Said, M. Ehlers	
	
Screening for Clostridioides difficile colonization at admission and during hospitalization N. Khanafer* (Lyon, France), S. Bennia, G. Martin-Gaujard, L. Juillard, T. Rimmelé, L. Argaud, P. Cassier, O. Martin, P. Vanhems	
	
Revolutionizing CDI treatment: Are shorter antibiotic regimens the future M. Duricek* (Prague, Czech Republic), J. Benes, K. Halmova	
	
Extended-pulsed fidaxomicin versus conventional dosing in patients at high risk of recurrence of Clostridioides difficile infection E. Rubio-Martín* (Seville, Spain), R. Escudero-Sánchez, Á. Gutiérrez Liarte, A. Ibañez Zurriaga, C. Saez Bejar, B. Díaz Pollán, C. Marcelo Calvo, G. Ruiz Carrasco, G. Pérez Caballero, A.M. Rodríguez Benavente, S. De La Villa, J.D. Ruiz-Mesa, L.F. Caballero Martínez, I. Márquez Gómez, E. Calabuig, M. Tasias, R. Blanes, M.Á. López Zúñiga, J. Rodríguez Granger, P. Merino Amador, A. Salinas, D. Rodríguez-Pardo, M. Villamarín Merlo, G. Maestro De La Calle, J. Mateo Flores, J.B. Pérez Gilaberte, R.M. Martínez Álvarez, F. Martínez García, N. Cobos-Trigueros, J. Llenas-García, M. Solivella- Rodríguez, L. Ramos Merino, B. Castelo López, M.M. Montero, D. Echeverría-Esnal, J. López-Contreras, P. Duch Llorach, M.R. Oltra-Sempere, C. Pinto-Pla, Í. Pineda, J.L. Del Pozo, J. Rodríguez-Baño, A. Halperin, A. Muriel García, S. Moreno Guillén, J. Cobo	
	
Gut phageome profiling in Clostridioides difficile infection and faecal microbiota transplantation C. Chen* (Lausanne, Switzerland), T. Pillonel, J. Schaer, G. Greub, G. Resch, B. Guery, C. Bertelli, T. Galpérine	
	
1-hour Oral Session Microbiome Dynamics and Health: From Pathogenesis to Therapeutic Potential	Chairs Mauricio Farfan (Santiago, Chile) Eija Inkeri Könönen (Turku, Finland)
	
Multi-omics integrated analysis revealed the key role of Fusobacterium periodonticum in colorectal tumorigenesis by decanoic acid promoting neutrophil chemotaxis. X. Chu* (Beijing, China), Q. Yang	
	
Exploring the respiratory microbiome in COPD patients: The role of Haemophilus spp. in disease pathogenesis P. Camps-Massa* (Barcelona, Spain), L. Saiz-Escobedo, J. Guerrero, E. Cuevas, D. Guevara- Nuñez, F. Tubau, J. Burgos, M. Lopez, A. González- Díaz, C. Ardanuy, M. Dominguez, S. Santos, S. Martí	
	
Using the in vitro MiGut system to simulate the ulcerative colitis microbiome and post-antibiotic recovery supported by a pre-defined consortium of microbes I. Moura* (Leeds, United Kingdom), W. Davis Birch, N. Beauchemin, M. Vulic, K. Bentley, P. Culmer, M. Mayol, C. Ford, M. Henn, E. Halvorsen, M. Wilcox, N. Kapur, A. Buckley	
	
Functional characterization of the Brazilian Yanomami microbiome along an urbanization gradient: Insights into the impacts of Westernization on human health M. Thorp* (Gent, Belgium), C. Callewaert, B. De Pessemier, D. Good, E. Allen-Vercoe, L. Paulino, L. Vereecke	
	
Colonization resistance of the intestinal microbiota to multidrug-resistant bacteria?	K. Villageois-Tran* (Bobigny, France), C. Emavivie, H. Skerdi, E.N. Saad, M. Julie, E. Ruppé
	
Meet-the-Expert Long acting injectables to treat and prevent infections: an example from HIV field	
	
Monica Gandhi (Salt Lake City, United States)	
	
Pedro Cahn (Buenos Aires, Argentina)	
	
1-hour Oral Session How to evaluate AMS programs	Chairs Esther Calbo (Terrassa, Spain) Sabiha Essack (Durban, South Africa)
	
Preference-based instrumental variables for estimating the causal effects of antibiotic prescribing decisions in common infections: Assessing potential validity using CPRD data N. Nguyen* (Oxford, United Kingdom), K. Pouwels, J.V. Robotham, S. Yu, S. Wordsworth	
	
Novel antibiotic spectrum metrics to quantify the impact of antimicrobial stewardship: a multicentre study B. Moshy* (London, United Kingdom), R. Llewellyn, R. Lester, G. Pollara, T. Samuels, J. Sarah, B. Gemma, I. Balakrishnan	
	
Utilizing a weighted-incidence syndromic antibiogram to evaluate antimicrobial therapies and resistance trends in community-acquired infections in a community teaching hospital V. Huang* (Glendale, United States), T. Pham, A. Vogler, H. Chhen, C. Vandenberg	
	
Capturing days of therapy per days of service as a stewardship tool to identify outliers in prescribing broad-spectrum antimicrobials in the hospital setting A. Hopkins* (Livingston, United States), A. Farkas, S. Tamirisa, G. Severance, A. Yassin, E. Jaime	
	
Timing of Novel -Lactams vs. Alternatives in Hospitalized Patients with Gram-Negative Infections: Line of Therapy (LoT) Analysis Preliminary findings E. Yucel* (Rahway, United States), J. Min, Y. Wang, M. Vendetti, Y. Emre, R.K. Shields	
	
Meet-the-Expert How antimicrobial tolerance impacts polymicrobial biofilm-associated infections	
	
Hans Steenackers (Leuven, Belgium)	
	
Brian Conlon (Chapel Hill, United States)	
	
1-hour Case Session Bad bacteria	Chairs Maristela P. Freire (Sao Paulo, Brazil) Siegbert Rieg (Freiburg, Germany)
	
Vancomycin Dependent Enterococci: An evolutionary dead end or the ultimate evolution of a superbug R. Gupta (bagga)* (London, Canada), R. Gupta, A. Cabrera, A. Kanyua, F. Almutawa, J. Delport, K. Kavanoor Sridhar	
	
Whipple&#39;s disease: one of medicine&#39;s great imitators S. Kesavan* (Nottingham, United Kingdom), F. Heard, S. Kesevan, E. Hart, V. Fleming, C. Santos, R. Thomson	
	
Phage Therapy as a Rescue Treatment for Recurrent Pseudomonas aeruginosa Bentall Infection V. Eiferman* (Paris, France), P.A. Vion, B. Rached, C. Granger, N. Hammoudi, A. Bleibtreu	
	
A clinical case of Legionella longbeachae pneumonia featuring unique epidemiological features in a major italian hospital S. Guerriero* (Rome, Italy), M. La Sorda, F. De Maio, S. Cardinali, M. Di Donato, P. Del Vecchio, C. Tarli, M. Fantoni, R. Murri, M. Sanguinetti, C. Torti	
	
Francisella tularensis – First autochthonous case in the UK G. Vanstone* (Truro, United Kingdom), A. Belfield, L. Vincent, V. Perks, D. Wadham, B. Marques Silva, A. Evans, O. Lloyd, N.C. Gordon, C. Arumugam, A. Ainarozidou	
	
Meet-the-Expert How to use large language models and machine learning for improving One Health	
	
Javier Fernández (Oviedo, Spain)	
	
Nicolas Radomski (Teramo, Italy) Co-organised with: ESCMID Food- and Water-borne Infections Study Group (EFWISG), ESCMID Study Group for Epidemiological Markers (ESGEM), Portuguese Society of Microbiology (SPM)	
	
Open Forum Science communication in a noisy world: podcasting and social media in ID/CM	Chair Emily G. Mcdonald (Montreal, Canada)
	
The ID:IOTS guide to creating a successful CM/ID podcast&quot; Callum Mutch (Edinburgh, United Kingdom)	
	
Using social media for CM/ID education Scott Jake (Oakland, United States)	
	
Podcasting and social media for antimicrobial stewardship and pharmacy Erin Mccreary (Pittsburgh, United States) Co-organised with: CMI Communications Board of Editors	
	
ePoster Flash Session Vaccination uptake-challenges and opportunities	Chair Joanne M. Langley (Halifax, Canada)
	
Electronic nudges to increase influenza vaccination uptake among patients with heart failure: insights from 3 nationwide randomized trials enrolling &gt;2 million patients N.D. Johansen* (Hellerup, Denmark), M. Vaduganathan, A.S. Bhatt, D. Modin, B.L. Claggett, K.H. Janstrup, C.S. Larsen, L. Larsen, L. Wiese, M. Dalager-Pedersen, E.L. Dueger, S. Samson, M.M. Loiacono, R.C. Harris, L. Køber, S.D. Solomon, P. Sivapalan, J.U.S. Jensen, T. Biering-Sørensen	
	
Psychological Predictors of Influenza Vaccination Intent Among Healthcare Workers in Bulgaria P. Velikov* (Sofia, Bulgaria), V. Rangelova, Y. Axentieva, Y. Tcholakov, V. Borisova-Nenov, D. Ivanov, A. Zasheva, A. Hori	
	
Determinants of COVID-19 vaccine uptake in patients with hematologic malignancies: a nationwide cohort study Q. Hofsink* (Amsterdam, Netherlands), T. Osmenaj, B.I. Lissenberg-Witte, S. Hahné, J. Heijmans, I.S. Nijhof, A. Goorhuis, M.D. Hazenberg, C.E. Rutten, S. Haggenburg, P. Den Tex, A. Dinmohamed, J. Kemmeren, H. De Melker, S. Van Den Hof	
	
Inequality in vaccine uptake among children in Denmark in the national childhood vaccination programme A.C.M. Breschel* (Copenhagen, Denmark), A.V. Søndergaard, S.K. Nørgaard, B. Søborg, P.H. Andersend	
	
Prevalence and associated factors of parental refusal rates for routine immunisation: A cross-sectional study in Peshawar, Khyber Pakhtunkhwa, Pakistan- 2024 M. Hakim* (Hayat Abad Peshawar Kp Pakistan, Pakistan)	
	
Shingles Prevalence, Vaccine Awareness, and Acceptance in People Living with HIV D. Yaman* (Izmir, Türkiye), D. Akdağ, M. Taşbakan, H. Pullukçu, D. Gökengin	
	
Tick-borne encephalitis vaccine uptake, effectiveness, and impact in Sweden, 2018−2022 A. Palmborg* (Stockholm, Sweden), F. Angulo, P. Zhang, A. Pilz, J. Stark, M. Jennifer, L. Jodar	
	
Monkeypox (mpox) vaccination willingness and determinants among people living with HIV (PLWH) in turkey C. Boşnak* (Altındağ, Türkiye), T.K. Şahin, E. Erul, M.Ç. Sönmezer, A.Ç. Inkaya, S. Ünal	
	
ePoster Flash Session Viruses crossing the blood-brain barrier	
	
Clinical characteristics and outcome of Herpes simplex virus type 1 and varicella zoster virus encephalitis: A prospective population-based cohort study L. Duerlund* (Aarhus, Denmark), L. Larsen, M. Storgaard, H. Mens, L. Weise, M.P.G. Jepsen, B.R. Hansen, H.R. Von Lüttichau, C.Ø. Andersen, H. Nielsen, J. Bodilsen	
	
Arbovirus associated neurological disease in adults and children in Brazil: a multicentre case-control study S. Lant* (Liverpool, United Kingdom), R. Mehta, M.L. Brito Ferreira, C. Soares, R. Medialdea Carrera, M. Tulius, P. Brasil, C. Miguelote, A. Henriques Souza, M. Ellul, M. Griffiths, M.M. Jardim Rodrigues, R. Braga, L. Pamplona, C. Spitz, F. Militao, A. Rosala Hallas, G. Burnside, R. Vivancos, S. Leonhard, L. Rodrigues De Mendonça-Vieira, B. Jacobs, C. Brito, P. Sequiera, D. Brown, L. Turtle, R. Franca, A. Bispo, T. Solomon	
	
Challenges in managing Central nervous system infections: Battling the Unknown Enemy, West Nile virus vs unknown etiology C. Marin* (Bucharest, Romania), A. Paun, E. Nedu, S. Tetradov, S. Lazar, M. Nica, G. Tardei, I.A. Condurache, S.A. Florescu, S.M. Ruta, C.P. Popescu	
	
Spatial and temporal profiling of the immune responses induced by Japanese encephalitis virus in a mouse model Z. Ou* (Shenzhen, China), Z. Wang, Q. Chen, X. He, P. Ren, J. Li, G. Cheng	
	
Intrathecal immunoglobulin synthesis in tick-borne encephalitis S. Grygorczuk* (Bialystok, Poland), P. Czupryna, D. Martonik, J. Dunaj-Małyszko, J. Adamczuk, A. Parfieniuk-Kowerda, J. Osada, A. Moniuszko-Malinowska	
	
B and T cell responses to Tick-borne Encephalitis Virus N. Mayola Danes* (Stockholm, Sweden), R. Varnaitė, N. Mayola Danés, K. Blom, H.G. Ljunggren, S. Gredmark-Russ	
	
Enterovirus infections in pediatric central nervous system (CNS) diseases: molecular epidemiology and neuroimaging insights D. Sharma* (Chandigarh, India), R. Pathania, P. Bhattacharya, M. Gautam, A. Bansal, S. Vyas, A. Ghosh, K. Goyal, M. P Singh	
	
Neuroimaging findings and their correlation with autopsy findings: Prospective study on Rabies encephalitis M. Mohata* (New Delhi, India), V. Suri, P. Singh, G.K. Mohi, A. Bhalla, R. Mohindra, R.K. Soni, K. Gupta	
	
Toxoplasma gondii IgG Screening and Central Nervous System Complications among People with HIV in the Combination Antiretroviral Therapy Era T. Ou* (New Taipei City, Taiwan, China), T.Y. Tsai, S.H. Huang, T.Y. Wu, W.D. Liu, H.Y. Sun, K.Y. Lin, C.C. Hung	
	
ePoster Flash Session AMS around the world: know your data!	Chair Eoghan De Barra (Dublin, Ireland)
	
Duration of antibiotic treatment for respiratory tract infections in primary care. C. Llor* (Barcelona, Spain), M.P. Hansen, J. Lykkegaard, J.K. Olsen, B.H. Lindberg, I.K. Rebnord, R. Radzeviciene, L. Jaruseviciene, P.T. Lundgren, P. Bruno, A. Kowalczyk, C. Lionis	
	
Antibiotic prescribing for common acute infections in Pakistan - an analysis using IQVIA prescriber healthcare surveys N. Nguyen* (Oxford, United Kingdom), K. Pouwels, M. Sharland, S. Mangla, A. Cook, M. Thorn, P. Stephens	
	
Antibiotic prescribing for common acute infections in Egypt - an analysis using IQVIA prescriber healthcare surveys N. Nguyen* (Oxford, United Kingdom), S. Mangla, A. Cook, M. Thorn, P. Stephens, K. Pouwels, M. Sharland	
	
Population based analysis of the impact of Japan&#39;s AMR national action plan and the COVID-19 pandemic on antimicrobial prescription R. Koizumi* (Tokyo, Japan), S. Tsuzuki, Y. Asai, K. Aoyagi, N. Ohmagari	
	
Quality of antibiotic prescribing in Portuguese hospitals: a snapshot of the first National Antimicrobial Prescribing Survey. C. Palos* (Lisbon, Portugal), C. Ierano, R. James, J.A. Paiva, K. Thursky, P. Sousa	
	
Evaluating the impact on 28-day mortality of different empiric AWaRe antibiotic treatment strategies for hospital-acquired infections across different hospital settings. C. Lim* (Oxford, United Kingdom), K.B. Pouwels, D. Limmathurotsakul, Q. Gu, D.E. Eyre, A.S. Walker, M. Sharland, B.S. Cooper	
	
Update on WHO&#39;s Global antibiotic use surveillance system (GLASS-AMU) B. Huttner* (Geneva, Switzerland), A. Muller, M. Escher, V. Ivanoska, D. Tong	
	
Harmonisation trajectory of Global-Point Prevalence Survey (Global-PPS) and WHO-PPS A. Versporten* (Antwerp, Belgium), A. Muller, M. Escher, I. Pauwels, D. Tong, A. Boven, V. Ivanovska, B. Huttner, E. Vlieghe	
	
Implementation of prospective audit and feedback strategy in intensive care units: Analysis of antimicrobial prescription patterns in a Guatemalan tertiary care hospital N. Sandoval* (Guatemala, Guatemala), G. Ozaeta, G. Reyes, K. Carrascosa	
	
Keynote Lecture Defending against dengue: global epidemiology and strategies for prevention and control	Chairs Anu Kantele (Helsinki, Finland) Carlos Seas (Lima, Peru)
	
Fernanda Boulos (São Paulo, Brazil)	
	
hour Oral Session Carbapenem resistance Gram-negatives, what&#39;s new in treatment?	Chair Maria Milagro Montero (Barcelona, Spain)
	
Ceftriaxone sulbactam disodium EDTA combination(CSE) as a treatment option for carbapenem resistant gram negative bacilli - to be or not to be?	Y. Verma* (Hisar, India), K. Narang, D. Bandlish, C. Sharma
	
Sulbactam-durlobactam as an effective alternative option against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam- resistant isolates in Swizterland C. Le Terrier* (Fribourg, Switzerland), P. Nordmann, A. Delaval, L. Poirel	
	
Optimising Difficult-to-treat Gram-negative Bacterial Infection Outcomes with Personalised Fosfomycin-Based Combination Therapy Guided by in vitro Antibiotic Combination Testing T. Lim* (Singapore, Singapore), J.Q. Teo, J.J.Y. Ho, T.G. Lee, L.J. Sin, K.K.K. Goh, N. Mohamed Yusoff, W. Lee, N.G.S. Chua, J.S. Chung, A.L.H. Kwa	
	
Management of infections caused by ST308 New Dehli metallo- ß -lactamase-producing Pseudomonas aeruginosa with in vitro -guided combination antibiotic therapy J. Teo* (Singapore, Singapore), J.H. Toh, H.Y. Chang, S.H. Tan, W. Lee, T.P. Lim, Y.E. Tan, S.J. Chung, A.L.H. Kwa	
	
In vitro activity of cefepime/enmetazobactam against clinical isolates of Enterobacterales in Portugal: A multicentre retrospective study H. Cruz* (Porto, Portugal), C. Chaves, L. Carneiro	
	
1-hour Oral Session Staphylococcus aureus : colonisation, virulence, and persistence	Chair Stefano Giulieri (Melbourne, Australia)
	
The nasal microbiome redefines and predicts Staphylococcus aureus nasal colonisation status D. Aggarwal* (London, United Kingdom), K.L. Bellis, B. Blane, M.C. De Goffau, J. Wagner, D.Y.K. Ng, K.E. Raven, P. Naydenova, S. Kaptoge, R. Henry, C. Perry, M.R. Walker, C. Churcher, S. Girgis, C.R. De Sousa, L. Sarkane, J. Brennan, S. Duthie, E. Johnson, M. Juhasz, S. Irvine, A. Mcmahon, A. Van Tonder, E. Di Angelantonio, A. Butterworth, J.A. Geoghegan, J. Danesh, J. Parkhill, S.J. Peacock, E. Harrison	
	
Development of a Staphylococcus aureus human nasal colonisation model A. Hachani* (Melbourne, Australia), B. Tran, E. Cho, R. Guérillot, B. Howden, T. Stinear, E. Vincan	
	
Selection-free, virulence gene promoter-controlled CRISPR interference system for in vivo pathogenesis study of Staphylococcus aureus - A proof of concept R. Miah* (Tromsø, Norway), M. Johannessen, M. Kjos, C. Lentz	
	
Placebo-controlled study of competitive exclusion using Lactococcus lactis to reduce transmission of LA-MRSA from pigs to humans B. Duim* (Utrecht, Netherlands), A. Vlasblom, A. Rittscher-Fogg, R. Rattigan, L. Wajda, D. Crespo-Piazuelo, M. Broekhuizen-Stins, L. Portengen, G. Van Eijden, C. Elend, S. Patel, L. Smit, M. Claesson, P. Lawlor, A. Zomer, J. Wagenaar	
	
Rifampicin-induced Staphylococcus aureus persister formation is driven by CodY and oxidative stress level N. Pordone* (Lyon, France), J. Guillemot, K. Rodriguez, N. Personnic, E. Botelho-Nevers, P.O. Verhoeven	
	
1-hour Symposium Value-based syndromic diagnostics in medical microbiology: Pro / Con debate	Chairs Hege Vangstein Aamot (Lørenskog, Norway) Eric Claas (Leiden, Netherlands)
	
Pro: clinical benefit and potential for improved patient outcomes Kirstine K. Søgaard (Aalborg, Denmark)	
	
Con: limitations, costs, and possible overuse of syndromic panels Gilbert Greub (Lausanne, Switzerland) Co-organised with: ESCMID Study Group for Genomic and Molecular Diagnostics (ESGMD), Société de Pathologie Infectieuse de Langue Française	
	
1-hour Symposium We need to talk about toilets…	Chairs Stephanie J. Dancer (Glasgow, United Kingdom) Juliette Severin (Rotterdam, Netherlands)
	
Infection risks from sanitation engineering Davey Jones (Bangor, United Kingdom)	
	
Ventilation in toilets: how can we improve it?	Michael Gormley (Edinburgh, United Kingdom) Co-organised with: ESCMID Food- and Water-borne Infections Study Group (EFWISG), ESCMID Study Group for Legionella Infections (ESGLI)
	
1-hour Oral Session Unlocking the potential of the human microbiome for clinical diagnostics	Chairs John W. A. Rossen (Groningen, Netherlands) Maria Vehreschild (Frankfurt Am Main, Germany)
	
Deep learning-enhanced wellness scores: Advancing gut microbiome-based health predictions O. Nalbantoglu* (Kayseri, Türkiye), A. Gundogdu, B.H. Ermis	
	
Comparison of Second-Generation and Third- Generation Sequencing technologies for 16S rRNA amplicon-based gut microbiome analysis E. Rubio García* (Barcelona, Spain), E. Rubio-García, A. Pulgarin, R. López-Aladid, L. Martínez-Priego, N. Palau, A. Mendoza, R. Isanta, A. Montalban, J.L. Villanueva-Cañas, M.M. Montero, M. Sanduzzi, M. Reig, C. Casals-Pascual	
	
Donor for fecal microbiota transplantation: a challenging research. B.S. Orena* (Milan, Italy), M.F. Liporace, A. Maraschini, D. Girelli, D. Pizzotti, E. Petrillo, C. Alteri, C. Amoroso, F. Caprioli, A. Callegaro, L. Cariani	
	
Antibiotic resistance genes diversity and antimicrobial effects in the vaginal microbiome during pregnancy N. Boutouchent* (Rouen, France), S. Kennedy	
	
Distinct gut microbiota and metabolic profiles in brain tumor patients: Bridging microbial insights to CNS oncology A. Gundogdu* (Kayseri, Türkiye), O.U. Nalbantoglu, M. Ulgen, M.A. Sav, G. Ekinci, H.F. Kelestimur, U. Ture	
	
Meet-the-Expert Untangling the web: antimicrobial dose adjustments in renal impairment	
	
Claire Roger (Nimes, France)	
	
Isabel Spriet (Leuven, Belgium) Co-organised with: ESCMID PK/PD of Anti-Infectives Study Group (EPASG), ESCMID Study Group for Critically Ill Patients (ESGCIP)	
	
1-hour Symposium Macrolides in community-acquired pneumonia: therapeutic necessity or path to overuse?	Chairs Marc J.M. Bonten (Utrecht, Netherlands) Karin Thursky (Carlton, Australia)
	
Pro: maximising outcomes with evidence-based use Evangelos Giamarellos-Bourboulis (Athens, Greece)	
	
Con: the risks of routine (over)use Aurélien Dinh (Garches, France)	
	
hour Symposium Top papers in transplant ID	Chairs Nicolas Mueller (Zurich, Switzerland) Alessandra Mularoni (Palermo, Italy)
	
Top 10 papers in infections in SOT Patricia Munoz (Madrid, Spain)	
	
Top 10 paper in infections in HCT and cellular therapy Joshua Hill (Seattle, United States)	
	
hour Oral Session Bacterial battles: a paediatric perspective on infections and interventions	Chairs Angelika Berger Julie Toubiana (Paris, France)
	
Strong Alignment Between National Standard Treatment Guidelines and WHO AWaRe Book Recommendations for Primary Care Pediatric Infections D. Dona* (Padova, Italy), D. Donà, G. Brigadoi, A. Cantarutti, M. Masetti, G. Autore, S. Mathur, M. Sharland, S.M.R. Esposito	
	
Correlation between antibiotic consumption and digestive colonization with multidrug-resistant Enterobacterales in a paediatric haematology department S. Frigui Ep Oueslati* (Tunis, Tunisia), N. Fitouri, S. Frigui, Y. Chebbi, I. Fezaa, M. Ouederni, C. Drira, W. Achour	
	
Interleukin-6 as a diagnostic biomarker for sepsis in neonates, children and pregnant women – a real- world cohort study Sean Olann Whelan (Dublin, Ireland)	
	
Impact of rapid diagnostic stewardship interventions to reduce blood culture utilization in a pediatric medical center E. Vaugon* (Los Angeles, United States), C. Costales, T. Barter, L. Posch, E. Orgel, J. Dien Bard	
	
Infective endocarditis: A Decade of Experience at a Tertiary Pediatric Care Centre M. De Luca* (Rome, Italy), R. Iacobelli, S. Samperi, S. Mercadante, L. Romani, L. Ragni, P. Bruno, G. Brancaccio, F.I. Calò Carducci, P. Bernaschi, A. Rizza, L. Lancella, L. Galletti	
	
Educational Session The rare art of writing scientific articles: from conception to submission	Chairs Marlieke De Kraker (Geneva, Switzerland) Mical Paul (Haifa, Israel)
	
Expressing yourself correctly: writing tips Angela Huttner (Geneva, Switzerland)	
	
Constructing your manuscript for an original article Jesús Rodríguez-Baño (Seville, Spain)	
	
The use of artificial intelligence tools for writing articles: what to do and not to do Erlangga Yusuf (Rotterdam, Netherlands)	
	
Selecting the best journal for my manuscript Andre Kalil (Omaha, United States) Co-organised with: CMI Board of Editors	
	
hour Symposium Controlled human infection models	Chairs Frederick Hayden (Charlottesville, United States) Nikolai Siemens (Greifswald, Germany)
	
Updates on the dengue human infection model Kirsten Lyke (Baltimore, United States)	
	
CHIM in endemic countries Melissa Kapulu (Kilifi, Kenya)	
	
Controlled human infection models of parasitic infections Meta Roestenberg (Leiden, Netherlands)	
	
Controlled human infection models of non-typhoidal SalmonellaMalick Gibani (London, United Kingdom) Co-organised with: British Infection Association (BIA)	
	
ePoster Flash Session Current treatment options for invasive fungal infections	Chair Andreas H. Groll (Münster, Germany)
	
The paediatric European Confederation of Clinical Mycology (ECMM) Quality (paed-EQUAL) Score for the management of candidaemia in children and neonates Z.D. Pana* (Nicosia, Cyprus), A.H. Groll, A. Bal, R. Sprute, F. Carlesse, S. Mellinghoff, S. Butzer, D. Ludwig-Bettin, K. Mehler, J. Stemler, D. Seidel, A. Marek, U. Ristau-Schäfer, O. Cornely	
	
Prevalence rate, species distribution and antifungal susceptibility of bloodstream infections caused by rare yeasts of the Saccharomycetales order documented in 28 Brazilian medical centers C. Palamin Buonafine* (São Paulo, Brazil), C.P. Buonafine, A.E. Dos Santos, L.M. Favarello, R.C. Cognialli, V.R. Aquino, C.B. Agnelli, A.V. Mendes, T. Guimaraes, T.C. Sukiennik, F. Carlesse, P.T. Castro, C.C. Baqueiro, E.C. Francisco, A.L. Colombo	
	
Rezafungin showed high in vitro activity and very low resistance rate against a collection of yeasts causing fungaemia in patients admitted to a tertiary hospital in Madrid from 2014 to 2024 J. Guinea* (Madrid, Spain), P. Escribano, A. Gomez, A. Burillo, P. Muñoz	
	
Posaconazole Drug-Drug Interaction Potential is Similar Across Bodyweight R.E. Wrishko* (Rahway, United States), P. Kothare, T.J. Bateman, M.G. Johnson, A. Stoch	
	
Phase 2, open-label, non-comparative clinical trial evaluating the safety and efficacy of posaconazole in paediatric patients 2 to &lt;18 years old with invasive aspergillosis H. Kang* (Seoul, Korea, Republic of), A.C. Arrieta, C. Dhooge, A. Kelemen, M. Macías-Parra, L. Aranda, Y.V. Dinikina, I. Kassis, S. Cesaro, T. Mackey, A. Shepherd, A.K. Shah, H. Waskin, M.G. Johnson	
	
Activity of manogepix against a worldwide collection of mould isolates from 2023 M. Winkler* (North Liberty, United States), S. Edeker, A. Klauer, P. Rhomberg, M. Castanheira	
	
Candida auris displays an inoculum effect with multiple antifungal drug classes R. Ben-Ami* (Tel Aviv, Israel), R. Shadhan, A. Novikov, N. Mizrahi	
	
In vitro olorofim activity against Aspergillus spp clinical isolates collected as part as two national surveys on azole resistance conducted in Spain ( ASPE IN II and III) J. Guinea* (Madrid, Spain), P. Escribano, J. Moraga, A. Gomez, P. Muñoz	
	
ePoster Flash Session Surgical site infections: epidemiology, risk factors, and prevention strategies	Chair Trisha Peel (Melbourne, Australia)
	
Incidence of Surgical Site Infections (SSIs) from the automated patient-based surveillance system, SPICMI, France P. Astagneau* (Paris, France), B. Nkoumazok, N. Benhajkassen, I. Arnaud, D. Verjat- Trannoy, J. Auraix, K. Lebascle	
	
Beta-lactam versus non-beta-lactam antimicrobial prophylaxis and its association with the surgical site infection rate, a nationwide cohort study with 348 793 patients S. Largiadèr* (Lucerne, Switzerland), D. Berthod, A. Widmer, N. Troillet, C. Perdrieu, S. Harbarth, R. Sommerstein	
	
Cutibacterium species in Neurosurgical Infections: Not Such a &quot;Cute&quot; Pathogen After All J. Donnelly* (Dublin, Ireland), B. Dinesh, S. O&#39;donnell	
	
The polymicrobial nature of wound infections in an emergency orthopaedic ward in Northern Nigeria - implications for treatment and patient outcome K. Cook* (Oxford, United Kingdom), F.S. Mohd, M.Y. Ahmad, A. Aliyu, K. Iregbu, C. Achi, T. Walsh, K. Sands	
	
Efficacy of Octenidine Dihydrochloride Versus Chlorhexidine Gluconate Solutions in Reducing Surgical-Site Infections in Total Hip and Knee Arthroplasty: A Comparative Analysis A. Abialevich* (Beer Sheva, Israel), V. Benkovich, G. Benkovich	
	
Impact on rates of surgical site infection of requiring pre-authorization of surgical antibiotic prophylaxis choice and post-operative antibiotic doses C.M. Villavicencio* (Taguig, Philippines), M.C. Hufano, R.R. Gabunada, Z. Alano	
	
2-hour Symposium STIs: an ongoing crisis	Chairs Dagmar Heuer (Berlin, Germany) Tomislav Mestrovic (Varazdin, Croatia)
	
STI treatment options are running out due to AMR Magnus Unemo (Örebro, Sweden)	
	
Genomic surveillance of Neisseria gonorrhoeae strains Petra Wolffs (Maastricht, Netherlands)	
	
Evolutionary insights into syphilis and Treponema pallidumMathew Beale (Hinxton, United Kingdom)	
	
Challenges in chlamydial STI infections Cecile Bebear (Bordeaux, France) Co-organised with: Deutsche Gesellschaft für Hygiene und Mikrobiologie	
	
hour Symposium Tick-borne encephalitis: contemporary diagnosis and management	Chairs Joanna Maria Zajkowska (Białystok, Poland) Dace Zavadska (Riga, Latvia)
	
Tick-borne encephalitis: immune response and clinical experience Sara Gredmark Russ (Stockholm, Sweden)	
	
TBE immune responses and vaccine effectiveness Karin Stiasny (Vienna, Austria)	
	
NS1 antibodies: diagnostics and screening of seroprevalence of TBE virus infection Gerhard Dobler (Munich, Germany)	
	
Treatment for TBE: where do we stand?	Daniel Ruzek (Brno, Czech Republic)
	
2-hour Oral Session The Trial Run: recent trials on S. aureus bacteraemia management	Chairs Julia Anna Bielicki (London, United Kingdom) Vance Fowler (Durham, United States)
	
Introduction , Julia Anna Bielicki (London, United Kingdom), Vance Fowler (Durham, United States)	
	
Description of SNAP trial	
	
Benzylpenicillin versus (flu)cloxacillin for the treatment of penicillin-susceptible Staphylococcus aureus bacteraemia: a randomised controlled trial of the S. aureus network adaptive platform (SNAP) S. Tong* (Melbourne, Australia), S. Aureus Network Adaptive Platform Trial Group	
	
Cefazolin versus (flu)cloxacillin for the treatment of penicillin-resistant, methicillin-susceptible Staphylococcus aureus bacteraemia: a randomised controlled trial within the S. aureus network adaptive platform (SNAP) J. Davis* (Newcastle, Australia), S. Aureus Network Adaptive Platform Trial Group	
	
Cloxacillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): a randomised, controlled, non-inferiority trial X. Lescure* (Paris, France), F. Vandenesch, X. Duval, S. Tubiana, C. Burdet, N. Saïdani, A. Lemaignien, E. Canoui, L. Surgers, M. Esposito Farese, V. Le Moing, P. Tattevin	
	
Trial Discussion Julia Anna Bielicki (London, United Kingdom)	
	
Trial Discussion Vance Fowler (Durham, United States)	
	
Open Discussion and Q&amp;A	
	
2-hour Oral Session Unraveling respiratory viruses, 2025	Chairs Eeva Broberg (Solna, Sweden) Florian Krammer (New York, United States)
	
Human metapneumovirus infections in hospitalized adults compared to respiratory syncytial virus and influenza infections over ten years in France P. Loubet* (Nimes, France), S. Guitton, R. Simon, L. Lefrancois, L.B. Luong Nguyen, P. Vanhems, F. Laine, F. Galtier, X. Duval, B. Lina, M. Valette, G. Lagathu, V. Foulogne, N. Houhou-Fidhou, A.S. L&#39;honneur, F. Carrat, L. Meyer, C. Durier, O. Launay	
	
Unveiling animal susceptibility to influenza viruses (H1N1(pdm09) and H5N1 HPAIV) using animal- derived respiratory organoids F. Tarrés-Freixas* (Bellaterra, Spain), G. Ceada, N. Navarro, M. Pérez- Simó, N. Carmona-Vicente, L. Bonillo-Lopez, A. Moreno, C. López, J. Segalés, N. Majó, K. Kochanowski, J. Vergara-Alert	
	
Exploring the impact of acute lung hypoxia on CD8 T cell phenotypes following severe influenza infection. B. Huckestein* (Memphis, United States), P. Thomas	
	
Virological characterisation of RSV after Nirsevimab Breakthrough Infections in a Multicentre Observational Real-world Study in France S. Fourati* (Créteil, France), A. Reslan, J. Bourret, Y. Rahou, L. Chollet, S. Pillet, P. Tremeaux, N. Candace Dossou, E. Gault, M. Salmona, B.M. Imbert, A. Mirand, S. Larrat, A. Moisan, S. Marot, A. Schnuriger, N. Veyrenche, I. Engelmann, L. Handala, A. Henry, V. Stephan, S. Brichler, V. Avettand- Fenoel, N. Zemali, C. Lefeuvre, C. Pronier, L. Deroche, M.C. Jaffar, L. Mouna, C. François, A. Regueme, C. Hartard, S. Roger, F. Gallais, A. Ly, C. Rodriguez, G. Dos Santos, J. Buchrieser, O. Schwartz, J.M. Pawlotsky, F. Lemoine, E. Audureau, M.A. Rameix-Welti	
	
Baseline immunity to highly pathogenic avian influenza viruses in a healthcare worker cohort C. Geurts Van Kessel* (Rotterdam, Netherlands), M. Power, W. Rijnink, L. Gommers, T. Bestebroer, W. Soochit, W. Tan, B. Verstrepen, S. Bogers, G. Van Nierop, R. Sikkema, A. Grifoni, A. Sette, M. Koopmans, R. Fouchier, M. Richard, R. De Vries, C. Geurtsvankessel	
	
Impact of reinfection on post-acute sequelae of COVID-19 over multi-organ systems J. Tan* (Singapore, Singapore), J.T. Lim, L.E. Wee, C. Chiew, B. Ong, D. Lye	
	
Clinical and economic burden of respiratory syncytial virus in adults with acute respiratory infections – a Danish nationwide cohort study Stanislava Bratkovic (Copenhagen, Denmark)	
	
The burden of respiratory syncytial virus in children &lt;3 years old presenting to primary, secondary and tertiary care in England: report from the STOP RSV prospective surveillance study E. Carter* (Liverpool, United Kingdom), H. Hill, D. Ferreira, A. Collins, C. Solórzano, L. Mclellan, L. Kerruish, F. Fyles, S. Drysdale, P. Gonzalez-Dias, G. Duncan, K. Davies, P. Crozier, P. Saunderson, R. Kramer, M. Bangert, N. Vassilouthis, S. Messahel, B. Caroline, S. Brearey, J. Bernatoniene, S. Bhowmik, J. Perry, P. Mottram, P. Mcnamara, D. Lewis, N. Van Kinnekan, A. Finn	
	
Targeted metagenomic sequencing of influenza, RSV, and symptomatic respiratory infections from UK healthcare workers M. Knoll* (Hinxton, United Kingdom), L. Findlater, B. Katie, J. Wagner, T. Diego, D. Rajan, S. Frances Field, S. Thurston, A. Wong, B. Hyatt, N. Thesin, J. Robinson, R. Yeadon, A. Galvin, B. Blane, Y.L. Huang, K. Howe, M. Forbes, K. Figueroa, F. Schwach, S. Stott, A. Marhino, A. Frick- Kretschmer, B. Dave, T. Maddison, S. Hopkins, S. Foulkes, J. Islam, A. Atti, V. Hall, E. Harrison	
	
2-hour Symposium PK/PD to avoid emergence of resistance?	Chairs Anne-Grete Märtson (Leiden, Netherlands) Joseph Meletiadis (Athens, Greece)
	
PK/PD and antibacterial therapy Dolors Soy-Muner (Barcelona, Spain)	
	
PK/PD and antifungal therapy Roger Brüggemann (Nijmegen, Netherlands)	
	
PK/PD and antiviral therapy Joe Standing (London, United Kingdom)	
	
PK/PD considerations in anthelminthic treatment Jennifer Keiser (Allschwil, Switzerland)	
	
Malaria: when the drugs don’t work Management of treatment failure in non- endemic countries Educational Session	Chairs Laura Nabarro (London, United Kingdom) Caroline Rönnberg (Stockholm, Sweden)
	
Malaria in the non-endemic setting: who to treat as an outpatient and how to detect treatment failure Emmanuel Bottieau (Antwerp, Belgium)	
	
Malaria resistance mutations in the non-endemic setting: role of genomic surveillance Anna Rosanas Urgell (Antwerp, Belgium)	
	
How to manage Plasmodium Knowlesi infection Giri Shan Rajahram (Kota Kinabalu, Malaysia)	
	
Epidemiology and control of Plasmodium KnowlesiKimberly Fornace (Singapore, Singapore) Co-organised with: British Infection Association (BIA)	
	
2-hour Symposium Gram-positives, are they still going?	Chairs Diederik Bathoorn (Groningen, Netherlands) Stefania Stefani (Catania, Italy)
	
The vanco chronicles: enterococci&#39;s global journey Guido Werner (Wernigerode, Germany)	
	
Pitfall in susceptibility testing of Gram- positives Helena Zemlickova (Prague, Czech Republic)	
	
Drivers for daptomycin and linezolid resistance in Gram-positives Glen Carter (Melbourne, Australia)	
	
What is new in treatment against MDR Gram- positives?	Alex Soriano (Barcelona, Spain)
	
2-hour Symposium Biomarker testing to manage respiratory infections in primary care in low resource settings	Chairs Sonia Lewycka (Hanoi, Vietnam) Heiman Wertheim (Nijmegen, Netherlands)
	
The Vietnamese experience with CRP testing in the community setting Thi Thuy Nga Do (Ha Noi, Vietnam)	
	
The Nigerian experience with CRP testing in the community setting Augustine Onwunduba (Awka, Nigeria)	
	
CRP testing in diagnosing tuberculosis in Zambia and South Africa Helen Ayles (Lusaka, Zambia)	
	
The health economics of CRP testing in LMICs Yoel Lubell (Bangkok, Thailand)	
	
ePoster Flash Session Genomics in pathogen surveillance	Chair Vítor Borges (Lisbon, Portugal)
	
Genomic Surveillance of Invasive Group A Streptococcus in Argentina&#39;s 2023 Epidemic: Unveiling Hypervirulent emm1 Lineages and Pediatric emm12 Burden L. Cipolla* (Buenos Aires, Argentina), A. Gianecini, T. Poklepovich, C. Giovacchini, M. Prieto	
	
Understanding the population structure of Moraxella catarrhalis using core-genome multilocus sequence typing I. Yassine* (Oxford, United Kingdom), K.A. Jolley, J.E. Bray, M.J. Jansen Van Rensburg, F. Patel, A. Sheppard, H.J. Zar, V. Allen, L. Ah Tow, M.C.J. Maiden, M.P. Nicol, A.B. Brueggemann	
	
Impact of the COVID-19 pandemic on the Streptococcus pyogenes clones causing adult invasive infections M. Ramirez* (Lisbon, Portugal), A. Friães, J. Vermeiren, R. Mamede, C.R. Bettencourt, M.P. Bajanca-Lavado, J. Melo-Cristino, P. Group For The Study Of Streptococcal Infections	
	
Unveiling the Hidden Complexity of Providencia : Genomic Insights into Species Reclassification and Antibiotic Resistance X. Dong* (Hangzhou, China)	
	
Genomic description of outbreak of VIM-1 carrying Enterobacter in Switzerland suggests plasmid transmission between sequence types H. Seth-Smith* (Zurich, Switzerland), M. Greutmann, C. Beckmann, E. Gruner, R. Capaul, G. Greub, P.M. Keller, S. Tschudin- Sutter, L. Berlinger, S.D. Brugger, T. Roloff, O. Nolte, L. Poirel, P. Nordmann, A. Egli	
	
Genomic epidemiology of Klebsiella pneumoniae bloodstream infections in a german tertiary centre: increased virulence in carbapenem-resistant strains L. Knegendorf* (Hannover, Germany), M. Lindenberg, C. Baier, J. Erdmann, S. Häußler, D. Schlüter	
	
Phylogenetic mixing and undetected circulation of multiple Candida auris lineages following recognition of imported cases in Italy V. Di Pilato* (Genoa, Italy), E. Willison, L. Calabrese, L. Magnasco, C. Elisa, G. Daniele Roberto, M. Mikulska, B. Matteo, M. Anna	
	
Using Long-Read Sequencing for Core Plasmid Multilocus Sequence Typing to Investigate Plasmid Relationships Among Bacterial Species in German Hospital Wastewater A.K. Bari* (Groningen, Netherlands), B. Sinha, J.W.A. Rossen, B.B. Xavier, T.T. Severs, M.J. Cardoso, M. Savin	
	
Screening for rectal colonization with multidrug- resistant pathogens: usage of rapid metagenomic long-read technology S. Purushothaman* (Zurich, Switzerland), A.M. Rooney, S. Moser, A. Egli	
	
ePoster Flash Session Heads up! CNS infections	Chair Jacob Bodilsen (Aalborg, Denmark)
	
Central Nervous System Involvement by Mycobacterium avium Complex in Advanced HIV: A Rare and Underdiagnosed Challenge E. Sienra Iracheta* (Tlalpan, Mexico), M. Aranda Aurelio, A. Camiro Zuñiga, D.H. Martínez Oliva, A. Llamas Lopez, A.P. Rodriguez Zulueta	
	
Acute disseminated encephalomyelitis following bacterial meningoencephalitis – Two Case reports &amp; Review of Literature M. Priyadarshi* (Delhi, India), M. Salunkhe, A. Mohan, P. Gupta, A. Agarwal, V. Goel, R. Bhatia	
	
Streptococcus equi Subspecies zooepidemicus Endocarditis and Meningitis in a 62-Year-Old Patient: A Case Report and Literature review D. Chemello* (Modena, Italy), G. Franceschi, S. Alessandra, B. Andrea, S. Mario, M. Marianna, M. Cristina	
	
Breaking barriers: meropenem-vaborbactam as a game-changer for KPC central nervous system infections F. Prataviera* (Udine, Italy), S. Giuliano, S. Flammini, J. Angelini, P.G. Cojutti, C. Tascini	
	
Multidrug-Resistant Klebsiella pneumoniae Meningitis in the Absence of Intracranial Devices: A Case Report M. Chumbita* (Barcelona, Spain), E. Viñas Esmel, P. Castro, S. Herrera, C. Bastida, A. Soriano	
	
Triple Threat: Sequential Meningitis Infections in an Immunosuppressed Patient with Morganella morganii, Acinetobacter baumannii, and Vancomycin-resistant Enterococcus faecium Y. Çakir Kiymaz* (Sivas, Türkiye), Y. Çakır Kıymaz, E. Kıymaz, Z. Bulut, S.A. Büyüktuna, N. Elaldı	
	
Invasive pulmonary Arthrographis kalrae infection with cerebral abscesses in an immunocompromised child B. Winkel* (Utrecht, Netherlands), J. Jans, M. Luesink, R.J. Nievelstein, F. Hagen, J. Buil, T. Wolfs, T. Van Der Bruggen	
	
Treatment of herpes simplex encephalitis with the helicase-primase inhibitor pritelivir in an immunocompromised patient A. Birkmann* (Wuppertal, Germany), C. Lueck, C. Rautenberg, S. Bonsmann, A. Marini, M. Sumner, T. Schroeder, S. Voigt	
	
A case of influenza A (H1N1) encephalitis: Rare neurological implication in a healthy adult N.K. Midha* (Jodhpur, India), S. Bhat K S, S. Tiwari, D.S. Meena, D. Kumar, G.K. Bohra 	
	
	
	